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Abstract 
 
The heart is reported to show a net consumption of lactate. This may contribute up to 15% to 
the total body lactate disposal. In this work, the consumption of lactate was shown for the first 
time on the single cell level with the new FRET-based lactate sensor Laconic.  
Research published until today, almost exclusively reports the monocarboxylate transporter 1 
(MCT1) as the transporter responsible for myocardial lactate uptake. As this membrane 
transporter transports lactate together with H+ in a stoichiometry of 1:1, lactate transport is 
coupled to pH regulation. Consequently, interactions of MCT1 and acid/base regulating proteins 
(carbonic anhydrases (CAs and sodium bicarbonate co-transporters (NBCs)) are described in 
the oocyte expression system, skeletal muscle and cancer cells.  
In this work it is shown that activity of extracellular CA increases lactate uptake into mouse 
cardiomyocytes by 27% and lactate induced JA/B by 42.8% to 46.2%. This effect is most likely 
mediated via NBC/CA interaction because inhibition of extracellular CA reduces HCO3--
dependent acid extruding JA/B by 53.3% to 78.4%. This may link lactate uptake to cellular 
respiration. When lactate was applied in medium gassed with 100% N2, lactate induced 
acidification was 12.6% faster than in medium gassed with 100% O2. Thus, CO2 produced on 
the pathway transferring redox energy from substrates like glucose and lactate to ADP and 
phosphate via oxidative phosphorylation, may support further lactate uptake. The findings of 
this work suggest an auto regulation of lactate uptake via CO2 release in ventricular mouse 
cardiomyocytes. 
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1. INTRODUCTION 
1.1 General  introduction 
 
Cardiomyocytes provide a simple activity to the heart: contraction and relaxation. Beside this, 
cardiomyocytes possess several processes from energy metabolism to signal processing at the 
same time. As they are the basic elements of the heart, the blood circulation and finally our life 
depend on their accurate function. Therefore they must, other than skeletal muscle cells, remain 
the whole life long constantly active. The biggest part of the redox energy, trapped in glucose 
is transferred to ADP + phosphate via oxidative phosphorylation (Pfeiffer et al., 2001). 
Accordingly, cardiomyocytes meet their energy needs on the oxidative pathway (Ventura-
Clapier et al., 2003). Several authors have reported that cardiomyocytes consume glucose and 
fatty acids but also lactate (Baker et al., 1998; Bergman et al., 2009; Gertz et al., 1988; Gladden, 
2007 review; Johannson et al., 2001; Kemppainen et al., 2002; Wahl et al., 2009 review). 
Mitochondrial activity is potentially involved in the formation of toxic reactive oxygen species 
(ROS) (Ghosh et al., 2005). This is important in view of cardiomyocytes’ low regenerative 
capacities (Poolman et al., 1998). Even though more recent research revealed much higher 
regenerative properties of the heart than previously expected, (Beltrami et al., 2001; 
Matsuyama and Kawahara, 2008) cardiomyocytes must be robust and enduring. Especially 
under the hyperglycemic conditions that are associated with diabetes, mitochondrial ROS 
formation may cause myocardial damage (Fiordaliso et al., 2004, Ghosh et al., 2005 and Ye et 
al.,2003). Thus, the handling of myocardial ROS is essential. 
However, lactate consumption in the human heart may increase from 35 µmol/min at resting 
conditions to 120 µmol/min during exercise (Gertz et al., 1988). Myocardial lactate consumption 
is supported by the properties of the LDH (lactate dehydrogenase) isoform present in the heart. 
The myocardial LDH is being inhibited by excess pyruvate (10 mM, in vitro, Dawson et al., 
1964). Thus, strong glycolytic activity and the resulting cytosolic pyruvate would rather inhibit 
the enzyme, whereas cells with strong respiratory activity should be able to keep the pyruvate 
level low and therefore allow the enzyme to produce pyruvate out of lactate.  
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Since the processes in the citric acid cycle and the previous formation of acetyl-CoA from 
pyruvate are accompanied by CO2 production, the respiratory consumption of lactate is 
connected to CO2 release (Gertz et al., 1988).  
1.2 H+ buffering and pH regulation 
 
CO2 will always be equilibrated with HCO3- + H+ as it is present in an aqueous environment. As 
consequence, altered CO2 concentrations go along with altered H+ concentrations. Beside this 
CO2 caused “respiratory acidosis”, further metabolic processes potentially generate H+ (Gevers 
et al. 1977). In the heart, the major H+ generating processes beside CO2 formation might be 
triglyceride synthesis and its degeneration as well as glycolysis, but not lactate formation 
(Gevers et al. 1977). A general reason for cytosolic H+ load might be the inward directed 
electrochemical gradient for H+ whose reversal potential lies between 0 and -30 mV (Deitmer 
and Chesler, 2009). In muscle cells, a raise in cytosolic H+ can reduce contractility (Chin and 
Allen, 1998) and may even cause arrhythmia (Vaughan-Jones et al., 2009). Such effects on 
cell physiology are avoided or reduced by H+ buffering. In general, cells provide two different 
H+ buffering systems. On the one hand, amino acids of cytosolic proteins may bind or release 
H+. Especially the amino acid histidine contributes to this intrinsic H+ buffering (Roos and Boron, 
1981). The intrinsic buffer may be further divided into mobile and immobile buffer (Vaughan-
Jones et al., 2002). The immobile fraction of intrinsic buffering is thought to be mediated by 
proteins that are either fixed to intracellular structures or so big that their diffusion coefficients 
are bigger than 10-8 cm2/s and are therefore considered to be immobile in relation to the speed 
of pH regulation (Zamboni et al. 2003). The mobile fraction of intrinsic buffering in 
cardiomyocytes provides a diffusion coefficient of 8-12 x 10-7 cm2/s (Zamboni et al. 2003) and 
is suggested to be mainly mediated by homocarnosine and phosphate (Vaughan-Jones et al., 
2002). On the other hand, the reversible hydration of CO2 (H2O + CO2  HCO3- + H+) 
provides a strong and dynamic system for H+ buffering (Casey et al., 2010). The strength of the 
buffering system is described by the buffer capacity. The buffer capacity describes the amount 
of H+ that has to be added to or removed from the cytosol to change the pH by one unit. The 
CO2/HCO3--independent buffer capacity is the so called intrinsic buffer capacity (βi). In rabbit 
cardiomyocytes, a βi of 26.4 mM was described by Vaughan-Jones et al. (2002). Zamboni et 
al. (2003) report a βi of approximately 30 mM at pH 7.0 that declines to 10 mM at approximately 
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pH 7.5 in guinea-pig, rat and rabbit cardiomyocytes. The CO2/HCO3--dependent buffer capacity 
(βCO2) was determined by Leem et al. (1999) in ventricular cardiomyocytes from guinea-pig to 
be approximately 20 mM at pH 7.0 and approximately 45 mM at pH 7.35. The sum of intrinsic 
and CO2/HCO3--dependent buffering system provide the total H+ buffer capacity (βtot), which is 
at the basal pH of 7.2 approximately 50 mM in guinea-pig cardiomyocytes (Leem et al., 1999).  
Beside this cellular buffering capacity, tissues provide additional mechanisms for pH regulation. 
In cardiomyocytes, acid extrusion is reported to be mainly mediated by the sodium/H+ 
exchanger (NHE) and by the sodium/bicarbonate co-transporter (NBC). The main acid loaders 
are chloride/hydroxyl exchanger (CHE) and chloride/bicarbonate exchanger (CBE) (Vaughan-
Jones et al., 2009). This pH regulation has been suggested to be called H+ muffling to 
distinguish it from the H+ buffering (Deitmer, 1991; Thomas et al. 1991). Recent results by 
Theparambil et al. (2014) suggest that H+ muffling may not just be a slow regulator that brings 
the pH back to the baseline after a severe deflection, but may even dominate βtot. Thus, a cell’s 
ability to compensate net H+ in- or efflux depends on the three systems: intrinsic buffering, 
CO2/HCO3--dependent buffering and H+ muffling.  
1.3 Carbonic anhydrase 
 
The dynamics of the CO2/HCO3--dependent buffering system depend on the activity of carbonic 
anhydrase (CA), an enzyme that speeds up the conversion of CO2 to HCO3- + H+ and vice 
versa. The CA isoforms I, II, III, VII and XIII are found to be cytosolic, the CAV is found in the 
mitochondrial matrix and the isoforms IV, IX, XII, XIV and XV are found to be membrane bound 
(Supuran, 2008). Every mammalian tissue contains CA, just the composition of its isoforms 
differs (Gilmour, 2010; Spicer et al., 1979; Sly and Hu, 1995; Spicer et al., 1993; Hilvo et al., 
2005). This broad variety indicates the physiological importance and as consequence the CA 
provides adaption to various requirements.  
As broad the CA’s varieties, as diverse are its roles in physiology. Especially the physiological 
role of CAIII is puzzling. This isoform is reported to contribute up to 50% of the total cytosolic 
enzyme in red skeletal muscle from rat (Shiels et al., 1983; Shiels et al., 1984). However, the 
purified enzyme does not contribute to the conversion of CO2 to HCO3- + H+ (Schüler et al., 
2011), even though in Xenopus oocytes, heterologously expressing CAIII, activity was 
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observed (Schüler et al., 2011). This may indicate an activating factor present in intact cells. 
Some authors found a potential involvement of CAIII in reactive oxygen species (ROS) handling 
(Räisänen et al., 1999; Roy et al., 2009) and its high presence in adipocytes (Kim and Levine, 
2005; Spicer et al., 1990) may suggest an involvement in fatty acid handling. In any case, CAIII 
knockout mice do not show any phenotype (Kim et al., 2004) so that the question remains what 
this protein shall be good for at all. In general, the broad variety of CA isoforms makes it likely 
that the KO of a particular CA isoform can be compensated by other CAs (Sly and Hu, 1995; 
Pan et al., 2006). In contrast to the loss of CAIII, the loss of other CA isoforms may have severe 
consequences for the organism. Knock out animals show phenotypes that may reach from 
osteoporosis (CAII-KO; Margolis et al., 2008) to impaired fertility (CAIV-KO; Wandernoth et al., 
2010) or infertility (CAIV/CAXIV double KO; Shah et al., 2005).  
Older in vitro studies on the catalytic activity of the purified enzyme determined a CAII-
dependent speed up of several thousand times and declared the CAII as the fastest CA isoform 
(Forster and Crandell, 1975; Silverman and Lindskog, 1988). More recent studies on Xenopus 
laevis oocytes, heterologously expressing CAII (Schüler et al., 2011) or on brain tissue sections 
(Stridh et al., 2012) revealed a CAII-dependent speed up of 2 to 7 fold under physiological 
conditions. In addition, Schüler et al. (2011) found that the CAI was almost as fast as CAII when 
present in Xenopus oocytes. In that study, the enzyme concentration was not determined so 
that differences in the measured kinetics might be due to different enzyme concentrations. But 
considered together with the finding that purified CAIII is almost inactive but active when 
present in intact cells, one might conclude that enzyme kinetics determined in vitro, might not 
reflect its physiological activity. However, erythrocytes contain large amounts of CAI and CAII, 
so these isoforms participate in respiration (Poole and Halestrap, 1994; Roughton, 1935; Sly 
and Hu, 1995). 
The presence of a cytosolic CA in cardiomyocytes is controversial. Alvarez et al. (2013) 
detected the CAII in human and mouse heart on the RNA and protein level. Alvarez et al. (2007) 
detected the CAII on RNA and protein level the rat and mouse heart. Schroeder et al. (2013) 
reported CA-catalysed CO2 hydration in rat cardiomyocytes and could detect the CAII on the 
protein level. Villafuerte et al. (2014) reported intracellular and extracellular catalytic CA activity. 
Geers et al. (1992) could not observe CA activity in the cytosolic fraction of lysed rabbit hearts. 
Vuillemin and Pexieder (1997) detected the CAII on the protein level in the ventricle of the 
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embryonic mouse heart at the age of 13-16 embryonic days, but at later developmental stages 
the CAII signal disappeared from the ventricle on was observed in endothelial tissues instead. 
In contrast, different membrane bound CA isoforms were found in the heart. Scheibe et al. 
(2006) detected the isoforms CAIV, CAIX and CAXIV on the protein level in mouse 
cardiomyocytes. Alvarez et al. (2013) detected the CAIV and CAXIV in the human and mouse 
heart. Geers et al. (1992) could detect CA activity in the membrane fraction of lysed rabbit 
hearts and Vandenberg et al. (1996) could observe CA activity only at the sarcolemma of 
cardiomyocytes from the ferret heart. Thus, strong evidence suggests membrane bound CA 
activity in mammalian cardiomyocytes, whereas cytosolic CA activity needs to be confirmed.  
1.4 Lactate transport 
 
Lactate transport across mammalian cell membranes is mainly mediated by MCTs 
(monocarboxylate transporters) (Pierre and Pellerin, 2005; Yanase et al., 2008; Bonen et al., 
2001; Vinnakota et al., 2011). The MCT isoforms 1-4 couple the transport of mono-
carboxylates, such as lactate, to H+ transport at a stoichiometry of 1:1 (Halestrap and Meredith, 
2004). The characteristic difference between the isoforms is their affinity towards substrates. 
This is described by the Michaelis-constant (Km), which is the substrate concentration at which 
the enzyme shows its half-maximal kinetic. For lactate, Km values of 0.75 mM, 3.5 mM and 28 
mM are reported for MCT2, MCT1 and MCT4, respectively (Bröer et al., 1998; Fox et al., 2000). 
Therefore, the MCT2 and MCT4 are widely considered as the high affinity and the high capacity 
specialist, respectively. According the neuron-astrocyte lactate shuttle hypothesis, astrocytes 
release lactate into the extracellular space from where it will be imported to neurons, which 
utilise lactate for ATP production via oxidative phosphorylation (Chih and Roberts, 2003). As 
the released lactate gets diluted in the extracellular space, in the brain the MCT2 is mainly 
associated with lactate uptake into Neurons due to its high affinity (Pierre and Pellerin, 2005). 
The low affinity but high capacity of the MCT4 let this transporter suit lactate producing and 
consequently releasing cells, like astrocytes (Pierre and Pellerin, 2005). A high capacity for 
lactate export becomes essential in cells whose rate of ATP production via glycolysis largely 
exceeds their rate of ATP production via oxidative phosphorylation, like in cancer cells or in 
white skeletal muscle (Kroemer and Pouyssegur, 2008; Pilegaard et al., 1999). In those cells, 
glycolysis ending with pyruvate would cause a NAD+ deficit and consequently ATP generation 
would get impaired. The reaction NADH + H+ + Pyruvate  NAD+ + Lactate allows the 
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continuous ATP production via glycolysis. This reaction gets further supported by a special 
feature of the MCT4. While MCT1 and MCT2 show higher affinity towards pyruvate in 
comparison to lactate, the Km for pyruvate transport via MCT4 is reported to be more than four 
times higher than for lactate (Km MCT4: lactate 28 mM, pyruvate 153 mM; Fox et al., 2000). 
This would rather trap pyruvate inside the cell and allow its conversion to lactate. The MCT1 
may be considered as all-rounder that suits the biggest part of metabolic needs, which might 
explain its almost ubiquitous distribution (Pierre and Pellerin, 2005; Poole and Halestrap, 1994).  
The MCT3 is a lactate transporter, restricted to the retina (Haletrap and Meridith, 2004). 
Therefore it will not be further discussed in this work. 
In the mouse heart, Dimmer et al. (2000) provided some evidence for MCT4’s presence on the 
RNA level but the only MCT isoform that has been found in the mammalian heart on the protein 
level is the MCT1 (Bonen, 2001; Evans et al., 2002; Johannsson et al., 2001). 
At this point, it should be briefly mentioned that in some studies an electrogenic lactate 
transporter (SMCT) that does not couple the lactate transport to H+ but to Na+ has been reported 
in the heart (Martin et al., 2006; Paroder et al., 2006). But this finding is controversial. Srinivas 
et al. (2003) could detect the mRNA of the SMCT with northern blot, whereas Gopal et al. (2004) 
could not detect the SMCT mRNA in mouse heart samples. Xiao and Allen (2000) performed 
sodium imaging on rat cardiomyocytes. They induced cytosolic sodium load by lactate 
application. But when they inhibited the NHE with cariporide, the lactate-induced sodium load 
was gone, which indicates the absence of a sodium-dependent lactate transporter in rat 
cardiomyocytes.  
However, all evidence points to the MCT1 as major lactate transporter in cardiomyocytes. 
Therefore, H+ buffering and muffling may directly contribute to the lactate transport. 
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1.5 Acid/Base regulation and lactate transport 
 
The lactate transport into cardiomyocytes is coupled via MCT to H+ transport. Therefore H+ 
buffering and muffling potentially interfere with lactate transport. The slow intracellular H+ 
diffusion as compared with its diffusion in unbuffered aqueous solution (8-12 x 10-7 cm2/s and 
9.3 x 10-5 cm2/s, respectively (Vanysek, 2000; Zamboni et al., 2003)) may cause an 
accumulation of H+ where it enters the cell (Vaughan-Jones et al., 2002). According to this slow 
cytosolic H+ diffusion, Spitzer et al. (2002) formulated the hypothesis that that H+ micro domains 
might form. In the case of lactate uptake into cardiomyocytes this would mean that H+ would 
accumulate in close proximity to the MCT in the cytosol. Thus, the inward directed H+ gradient 
would get reduced and the lactate uptake would slow down. In the presence of CO2/HCO3- 
buffer, the cytosolic H+ mobility increases by a factor of 2.7 (Zamboni et al., 2003), therefore 
the formation of H+ micro domains during lactate uptake might reduce. This increased H+ 
mobility in CO2/HCO3- buffer depends on the catalytic activity of the CA (Spitzer et al., 2002). 
In addition, the increased buffer capacity in the presence of CO2/HCO3- buffer would reduce 
the cytosolic acidification that is caused by MCT mediated lactate uptake. Consequently, lactate 
uptake into cardiomyocytes might be increased in CO2/HCO3--buffered conditions, depending 
on CA’s catalytic activity. Spitzer et al. (2002) refer the observed effect of CA activity on 
cytosolic H+ mobility to cytosolic CA. But, as previously mentioned, the cytosolic activity of CA 
in cardiomyocytes is controversial. In contrast, there is strong evidence for extracellular CA 
activity on cardiomyocytes. Several authors report a functional interaction of extracellular CA 
and NBC (Alvarez et al., 2003; Morgan et al., 2007; Loiselle et al., 2004; Orlowski et al., 2012, 
Stock and Schwab, 2009). Theparambil et al. (2014) could observe a strong impact of the NBC 
on the buffer capacity in cultured mouse astrocytes. Therefore, the effect of CA on the H+ 
mobility in CO2/HCO3- buffer, as reported by Spitzer et al. (2002), might also be due to an 
indirect effect via NBC.  
Wetzel et al. (2001) could show that inhibition of extracellular CA inhibits lactate uptake into 
skeletal muscle. This observation might point to a functional interaction of MCT and 
extracellular CA. But if it is taken into account that a functional interaction of MCT and NBC has 
been observed when expressed in Xenopus laevis oocytes (Becker et al., 2008), then it might 
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be that the observed effect of extracellular CA on lactate uptake (Wetzel et al., 2001) is the 
result of an indirect CA/MCT interaction via NBC (CANBCMCT).  
Beside a catalytic effect of CA on the lactate flux, an interaction of MCT and CA, independent 
of CA’s catalytic activity, was found.  
 
A 
B 
Figure 1 Scheme of potential non-catalytic interaction of MCT1 and extracellular CAs in mouse 
A Isolated cardiomyocyte from a p15 mouse. The nuclei are stained with Hoechst and are shown in blue. The 
green signal results from an unspecific approach in immunocytochemistry for CAII. Nevertheless, it nicely 
highlights the cell’s sarcomeres. B Hypothetical model of non-catalytic interaction of MCT and extracellular CA. 
The MCTs are mainly located in the intercalated discs, which are indicated as grey strings. 
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In Xenopus oocytes, heterologously expressing MCT1 and the intracellular CAII, the lactate 
uptake was faster than in oocytes expressing MCT1 alone, even when treated with the CA 
inhibitor 6-Ethoxy-2-benzothiazolesulfonamide (EZA) (Becker et al., 2005).  
This interaction was also observed for the extracellular CAs CAIV (Klier et al., 2013) and CAIX 
(Michael Klier, unpublished data). The observed effect was finally formulated as hypothetical 
H+ collecting/scattering antenna, formed by membrane associated CAs (Becker et al., 2011). 
Basically, CAs are thought to provide conductor quality for H+ along cell membranes, 
independent of their catalytic activity. Like this, the low cytosolic H+ mobility could be 
compensated. Such “antennae” might also include other proteins than CA’s, especially outside 
the heterologous expression system, but CA’s are likely to form the essential link between MCT 
and H+ conductor.  
This “antenna” might enhance lactate uptake into cardiomyocytes. Especially if it is taken into 
account that MCT1 is reported to be mainly expressed at the rather small area of intercalated 
discs (Garcia et al., 1994; Johannson et al., 2001). Like this, the whole cell surface would form 
an H+-catchment area of the very locally active MCT (Figure 1).  
Another pH regulator that might contribute to the lactate uptake into cardiomyocytes is the 
Na+/H+ exchanger (NHE). As its name already explains, this membrane transporter provides 
the exchange of Na+ and H+. Since the gradient for sodium is steeply inward directed, the NHE 
provides an acid extruding activity. The NHE1 is the only isoform known to be expressed in the 
heart (Ch’en et al., 2008).  
Similar to MCT and NBC, NHE1 may interact with CAs. For NHE1 and CAII, functional and 
physical interactions were described (Li et al., 2002; Orlowsky and Grinstein, 2004).  
The contribution of NHE1 to lactate uptake into the heart is controversial. On the one hand, 
NHE1 contains an H+-sensitive domain that will allow transport activity only beyond a particular 
threshold of H+ concentration (Wakabayashi et al., 1997). Leem et al. (1999) reported an 
increase of NHE-dependent acid extrusion at pH < 6.9 in guinea-pig cardiomyocytes. Thus, the 
NHE may support the lactate uptake via MCT if the cytosolic pH drops below pH 6.9. According 
to Kemppainen et al. (2002) the human blood lactate level may reach a concentration of 10 mM 
at strong physical activity. If it is assumed that this would lead to a cytosolic load from 0 to 10 
mM lactate and that the buffer capacity is 50 mM (Leem et al. 1999), the cytosolic pH would 
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drop by ∆pH 0.2. Consequently, only in cells with a basal pH ≤ 7.1 the cytosolic raise in lactate 
concentration from 0 to 10 mM would cause a drop in cytosolic pH that may reach pH 6.9 and 
therefore potentially activate the NHE. The average basal pH in cardiomyocytes is reported to 
be pH 7.2 (Vaughan-Jones et al., 2009), so that just individual cardiomyocytes might possess 
a basal pH ≤ 7.1. Additionally, the basal cytosolic lactate level might not be zero and the raise 
in blood lactate level would not occur instantaneously. Thus, the gradient for lactate influx might 
be lower than assumed and cellular pH regulating mechanisms might be able to maintain the 
cellular pH meanwhile the cell is loading lactate. Therefore, the involvement of NHE in lactate 
uptake via MCT appears to be unlikely. 
On the other hand, the NHE1 was found to be mainly located in intercalated discs (Garciarena 
et al., 2013; Halestrap et al., 1997), which is the same subcellular localization that had been 
reported to show the highest MCT1 level, as mentioned above. This co-localization indicates 
the possibility of a functional interaction of MCT1 and NHE1 in cardiomyocytes. 
In Figure 2, pH regulating processes potentially involved in lactate transport in cardiomyocytes 
are summarized. CAs might support the lactate flux in a catalytic-dependent manner by 
supporting the H+ mobility and the buffer capacity via NBC. In addition, CAs might participate 
in an H+ conductor along the intra- and extracellular cell surface that counteracts the low 
intracellular H+ mobility and thereby supports the MCT. If active, the NHE could counteract the 
cytosolic H+ load, caused by lactate uptake via MCT. 
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Figure 2 Acid/base regulation potentially involved in cardiomyocytes’ lactate uptake  
Extra- and intracellular CAs may support the lactate uptake, depending on CA’s catalytic activity and in a non-catalytic 
manner. The cardiomyocytes’ main acid extruders are NHE and NBC. Those are known to provide functional 
interaction with CAs.  MCT: monocarboxylate transporter; NBC: Na+/HCO3- co-transporter; NHE: Na+/H+ exchanger; 
CA: carbonic anhydrase 
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1.6 Motivation 
 
Cellular pH regulation (Figure 2) and metabolism are complex when considered individually. 
However, their interplay is obvious as it is widely believed that cellular activity goes along with 
H+ release. In muscle, pH regulation defines performance. Messonnier et al. (2007) described 
a positive correlation of skeletal muscle work rate and the abundance of the proteins MCT1, 
MCT4, NHE and CAIV. The origin of cytosolic H+ might be multifaceted and probably includes 
ATP hydrolysis and CO2 production. While the protons released at ATP hydrolysis will be 
trapped inside the cell and might therefore be reused to build up the H+ gradient between 
mitochondrial matrix and intermembrane space (Robergs et al., 2004), CO2 might leave the cell 
and acidify the extracellular space and neighbouring cells, too. At least in oxidative tissues, 
such as heart, it is likely that CO2 production is the main source of H+ (Gevers et al. 1977). The 
release of CO2 depends on the consumption of substrates in the citric acid cycle, which might 
link it, via CA and NBC activity, to the uptake of lactate.  
Therefore, the goal of this work was the investigation of the potential interplay of pH regulation, 
respiration and lactate uptake into mouse cardiomyocytes.  
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2. MATERIALS & METHODS 
2.1 Cardiomyocyte isolation and cultivation 
 
Cardiomyocytes were isolated from p20 ± 2 mouse hearts. The isolation method described here 
was newly developed for this project, based on transcardial perfusion (Figure 3) and the 
accumulated experience of several authors (Schlüter and Piper, 2005; Zhou et al., 2000; 
O’Connell et al., 2003; Louch et al., 2011; Sutherland et al., 2003; Volz et al., 1991). The major 
difference to the methods published until now is the omission of a Langendorff apparatus from 
an isolation protocol of adult cardiomyocytes, which provides a cheap and simple alternative. 
Additional explanations to the procedure are shown in italics. 
 
1) The animals were sacrificed by cervical dislocation or were decapitated 
2) The chest was opened with sharp scissors so that the heart got accessible 
3) The perfusion pump (ISMATEC) was started at a speed of 0.5 ml/min (perfusion with 
carbogen gassed Yog-Mod (Yogananda-modified, pH 7.2, room temperature; Table 1)).  
If the solution is already pumped out of the cannula when it gets injected, introduction of 
air bubbles to the vascular system is avoided. The solution was composed according to 
the recipe of Mr Markandeya (Markandeya et al., 2011) and modified with a low sodium 
concentration according to the findings by Ver Donk and Borgers (1991), Ruiz-Meana et 
al. (1999) and Ruiz-Meana and García-Dorado (2009), who described that Na+ may pass 
myocardial gap-junctions and propagate in the syncytium, causing cytosolic Ca2+ 
overload. Ca2+-free solution was used on the one hand to disrupt connections at 
intercalated discs, according to the findings of Muir (1967), and on the other hand to 
avoid hypercontration due to excessive Ca2+ influx. A pH between 7.0 and 7.2 was 
chosen according to the findings by O’Connell et al. (2003) and Kitakaze et al. (1988), 
who described better cell performance in slightly acidic environment. BDM is a standard 
drug to inhibit myocardial contraction. It’s interaction with the myosin/actin complex is 
described by Gwathmey et al. (1991). Potential side-effects are mentioned by Borlak 
and Zwadlo (2004). The benefit of using taurine reaches from preventing apoptosis 
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during ischemia (Devi and Anuradha, 2009), which may partially occur during the 
preparation procedure, to stabilization of the cell membrane (Huxtable and Bressler, 
1973).  
4) The perfusion was connected to the left ventricle via a cannula 
5) The perfusion speed was increased to 1 ml/min for 2 min 
6) The right atrium was opened so that fluid could leave the circuit.  
Otherwise the circular system would burst sometime in an uncontrolled manner, which 
might work too. 
7) The perfusion speed was increased to 2 ml/min for 3 min 
8) The pump was briefly switched off and the perfusion tube was transferred to collagenase 
containing perfusion solution (collagenase A from Roche; 0.5 mg/ml).  
Even though the solution was calcium free, the collagenase was expected to be active 
due to calcium released by the cardiomyocytes. 
9) After 4 min, 8 ml of 0.5% trypsin solution was added to the collagenase-containing 
medium (so the volume got filled up to 40 ml and the final trypsin concentration was 0.125 
%).  
In previous attempts, treatment with collagenase alone was not sufficient to liberate the 
cells from the tissue. As consequence, the cells were destroyed in steps 12 and 14. 
Addition of trypsin, even though rough and unspecific, solved this problem. 
10) Perfusion for 15 min.  
It appeared to be helpful to give some heart massage with forceps to support the capillary 
perfusion at this point.   
11) The ventricles were cut below the atria and transferred to a petri dish 
12) The ventricles were covered with 2 ml enzyme solution (from 9) and plucked to parts 
with sharp forceps  
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13) The tissue was transferred to a new petri dish (ᴓ 5 cm) filled with 4 ml of enzyme solution 
(from step 9) + 200 µl Insulin-Transferrin-Selenium-medium (ITS-medium; see at step 
25) and stored in an incubator at 37°C/ 5% CO2 for 15 min.  
Transferring the tissue parts to a new petri dish was helpful to remove dead, surficial 
cardiomyocytes, erythrocytes and debris, which may disturb cell attachment in step 22. 
14) The plastic tip of a 1000 µl pipette was cut with sterile scissors and then briefly flamed 
to get a smooth pipette mouth 
15) Cells were liberated by gentle pipetting  
16) The fragments that did not dissociate were removed and the cell suspension was 
transferred to a 15 ml tube containing 4 ml sterile filtered Yog-Mod and 1 ml ITS-medium 
(the suspension was carefully added to the surface of the solution so that the cells had 
to sink to the bottom).  
Most authors recommend to reintroduce Ca2+ in a stepwise manner after the liberation 
procedure, since immediate application of 2 mM Ca2+ will cause cytosolic calcium 
overload, followed by hypercontraction and cell death. Here, calcium was reintroduced 
in two steps (16 and 19) by mixing the calcium-free Yog-Mod solution and the ITS-
Medium, containing 1.8 mM Ca2+. Calcium reintroduction at room temperature instead 
of 37°C was described as beneficial by O’Connell et al. (2003). 
17) The cell suspension was stored at room temperature (RT) for 20 min to let the cells settle 
down, then the cell suspension was centrifuged for 3 min at 300 x g 
18) The supernatant was discarded except for the lowest ml and the cells were resuspended 
in the remaining solution. 
19) The suspension was transferred to a new 15 ml tube with 3 ml sterile filtered Yog-Mod 
and 2 ml ITS-Medium. 
20) The cell suspension was stored at RT for 20 min to let the cells settle down, then the 
tube was centrifuged for 3 min at 300 x g 
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21) In the meantime, petri dishes were coated with matrigel. A drop of 1.5 µl matrigel was 
placed in the centre of the petri dish and smeared with a sterile cell scraper on a patch of 
approximately 0.5 cm in diameter. Coated petri dishes were incubated for matrigel 
polymerization at 37°C for 20-30 min. 
It is important not to apply the gel too thick, otherwise it will swell and detach including 
the cells on it. 
22) The supernatant was discarded except for the lowest 1000-100  µl, in which the cells 
were resuspended. 
23) Finally, a drop of 50 µl of suspension was added to a matrigel coated petri dish and 
settled for 1 h in the incubator at 37°C/ 5% CO2. 
24) Cellular membrane integrity after the preparation was checked by Hoechst and 
propidium iodide application (Figure 4). 
25) If the cells were intended for cultivation, after 1 h the petri dishes were filled with 2 ml 
ITS-medium (Table 2).  
The utilization of DMEM D7777 was due to the availability since it’s one of the standard 
media used in this laboratory, but it was favoured over M199 according to Li et al. (2003) 
who described a reduced presence of coxsackie-adenovirus receptor in M199, which 
resulted in lower viral transduction yield. The benefits of taurine were mentioned above 
(step 3). Cultivation of cardiomyocytes for more than 1 day was problematic with media 
containing BDM. After a very helpful tip by Chad Touchbarry via Researchgate 
(www.researchgate.net), blebbistatin was used instead of BDM according to Kabaeva et 
al. (2008), who could show longer survival of cultured adult mouse cardiomyocytes if 
blebbistatin was used instead of BDM. In this work, the same beneficial effect of 
blebbistatin was observed. ITS was used instead of FCS (which was leading to 
circularization of cardiomyocytes) according to the findings of Sambrano et al. (2002) 
and Volz et al. (1991). Lactate was added because this work was focusing on lactate 
transport and the availability of lactate was thought to stimulate lactate transport 
mechanisms. However, addition of lactate (5 mM) seemed to improve cell viability. 
Matrigel as coating material was used because of its’ laminin content, which was 
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reported to provide good attachment of cardiomyocytes (Rogers et al., 2009; Lundgren 
et al., 1985) and specifically acts on β1-integrin surface receptors (Terracio et al., 1991), 
mimicking the interaction with extracellular matrix of the in vivo situation. 
 
 
Figure 3 Scheme of myocardial perfusion 
The arrows indicate the direction of perfusion. The medium was pumped into the left ventricle so that it had to 
leave the heart via the aorta. The heart arteries will branch off the aorta. As the vessel system will produce a 
resistance, the medium is thought to be forced into the heart’s capillary system from where it will finally drain into 
the right atrium. With a small cut in the right atrium the circuit got opened here so that the heart can be perfused. 
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Figure 4 Test for cell viability after isolation 
Cells were treated with Hoechst 33342 (16 µM; A) and propidium iodide (1.5 µM; B). Hoechst is membrane 
permeable and will therefore label nuclei of all cells. Propidium iodide is membrane impermeable and will only 
label dead or damaged cells. C Overlay of A, B and transmission light. D Overlay of Hoechst, propidium iodide 
(red) and transmission light from another frame, showing a propidium iodide-positive cell. The red arrow heads 
indicate apoptotic blastula. 
 
 
 
A B 
C D 
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Table 1 Medium for cardiomyocytes isolation (Yog-Mod) 
Chemicals in Yog-Mod concentration 
NaCl (Carl Roth) 56 mM 
KCl (Sigma Aldrich) 2.4 mM 
KH2PO4 (Riedel de Haën) 0.6 mM 
Na2HPO4 (Riedel de Haën) 0.6 mM 
MgSO4 (Sigma Aldrich) 3.2 mM 
NaHCO3 (Merck) 15 mM 
Taurine (Sigma Aldrich) 5 mM 
HEPES (Carl Roth) 10 mM 
Glucose (Sigma Aldrich) 5.5 mM 
Saccharose (Carl Roth) 120 mM 
2,3-Butanedione monoxime 
(BDM) (Sigma Aldrich) 
10 mM 
 
 
Table 2 Medium for cultivation of cardiomyocytes (ITS-Medium) 
Chemicals in ITS-Medium concentration 
DMEM D7777 (Sigma Aldrich) 1x 
Taurine (Sigma Aldrich) 2 mM 
NaHCO3 (Merck) 8 mM 
Creatine (Sigma Aldrich) 1.85 mM 
Blebbistatin (Sigma Aldrich) 25 µM 
insulin transferrin selenium (ITS) 
supplement (100x; Gibco) 
5x 
Na+-lactate (Sigma Aldrich) 5 mM 
Penicillin-Streptomycin (Sigma-Aldrich) 10 ml/l 
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Table 3 Further materials used for cardiomyocytes cultivation 
Materials 
Lactate sensor Laconic (Vector Biolabs) 
Pyruvate sensor (Gift from Felipe Barros) 
Petri dish (Falcon 0160) 
15 ml Tube (Orange Scientific) 
ECM-Gel (Matrigel; Sigma Aldrich) 
 
  
32 
 
2.2 Imaging 
 
 
Figure 5 Scheme of the imaging setup used at the LSM 700   
Schematic setting, used for imaging experiments at the Zeiss LSM 700. The isolated cardiomyocytes were fixed 
to a petri dish with matrigel. The medium was pumped with a peristaltic pump to the objective where it ran to the 
lens.  The medium was pumped out of the petri dish with the same pump, but the outlet was connected to two 
tubes so that it ran twice as fast as the inlet. SNARF was excited with a 555 nm laser. The emitted light was split 
into two spectra at 590 nm. The lactate sensor Laconic was excited with a 405 nm laser and the resulting emission 
spectrum was split at 508 nm according to Figure 11. VSD: variable secondary dichroic mirror. PMT: photon 
multiplier. 
 
All imaging experiments were performed with a Zeiss LSM 700 confocal microscope. The petri 
dishes of the cell cultures were used as bath chamber. The bath was perfused with a peristaltic 
pump (Ismatec) at a speed of 2 ml/min. The solution was entering the bath by running down 
the objective. This was leading to an immediate application in the focus and abolished the 
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common imaging problem of air bubble trapping. With the same peristaltic pump, the solution 
was pumped back from the bottom of the petri dish. To keep the volume as small as possible 
and to avoid spill over, the solution outlet was connected to two tubes, connected to the pump, 
so that the outlet would be about twice as fast as the inlet (Figure 5). Thus, inlet and outlet 
speed were coupled to each other and imaging disturbances caused by the perfusion were 
reduced. 
Table 4 Dyes used for pH imaging 
Dye Solvent Company Concentration 
used 
SNARF 5F (cytosolic pH sensor) DMSO Invitrogen (S 23923) 100 µM 
Fluorescein-DHPE (membrane 
bound pH sensor) 
Ethanol or 
DMF 
Invitrogen (F 362) 85 µM 
 
Table 5 Inhibitors used in imaging experiments 
Inhibitor Solvent Company Concentration 
used 
EZA (CA inhibitor, membrane 
permeable)  
DMSO Sigma Aldrich 30 µM 
AR C155858 (MCT1 inhibitor) DMSO AstraZeneca/Tocris 300 nM 
S0859 (NBC inhibitor) DMSO Sanofi-Aventis 30 µM 
NaN3 (respiratory chain complex IV 
inhibitor) 
H2O Fluka 5 mM 
Cariporide/ HOE642 (NHE1 
inhibitor) 
DMSO Santa Cruz 
Biotechnology 
30 µM 
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Table 6 Recipe of HEPES-buffered imaging solution. 
The pH was adjusted to 7.4 with NaOH. For CO2/HCO3--buffered imaging solution, 26 mM of NaCl were 
substituted with 26 mM NaHCO3. CO2/HCO3--buffered was contentiously gassed with carbogen (95% O2 / 5% 
CO2). 
Chemical Concentration 
NaCl (Carl Roth) 130 mM 
KCl (Sigma Aldrich) 1 mM 
KH2PO4 (Riedel de Haёn) 1.2 mM 
MgSO4 (Sigma Aldrich) 3.2 mM 
Taurine (Sigma Aldrich) 5 mM 
HEPES (Carl Roth) 5 mM 
D-glucose (Sigma Aldrich) 5.5 mM 
Saccharose (Carl Roth) 15 mM 
BDM (Sigma Aldrich) 5 mM 
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2.2.1 H+ imaging 
2.2.1.1 H+ imaging (SNARF) 
 
SNARF- (SemiNAphthoRhodaFluor) 5F 5-(and -6)-carboxylic acid (Invitrogen) is a pH sensitive 
fluorescent dye. Its emission spectrum shows an isosbestic point at about 590 nm (Figure 6), 
which provides the possibility of ratio metric imaging.  
 
Figure 6 Fluorescence properties of SNARF-5F  
A The pH-dependent absorption is shown. B The pH-dependent emission when excited at 550 nm is shown. 
This figure was modified from Hille et al., 2008. 
 
The emission spectrum fraction shorter than 590 nm is gaining intensity, whereas the emission 
spectrum fraction longer than 590 nm is losing intensity with increasing H+ concentration. In 
this work, these two fractions of the emission spectrum were separated with a dichroic mirror 
(VSD) and recorded separately on two different PMTs (photon multiplier) (Figure 5).  
λex=550 nm 
B A 
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Figure 7 Chemical structure of SNARF  
The chemical structure of the membrane-permeable ester form and the membrane impermeable acid form of 
SNARF are shown (modified from Invitrogen). Cleaved parts are shown in red. 
 
Finally, the signal <590 nm was divided by the signal >590 nm, which resulted in a signal ratio, 
therefore it is called ratiometric. Ratiometric imaging has the advantage over non-ratiometric 
imaging, that most artefacts due to multiple disturbances that may occur during a measurement, 
especially in perfused systems, will have the same impact on both emission fractions. Therefore 
they will be neutralized in the ratio. Also the incubation time of the dye or the exact concentration 
loaded do not alter the signal. In Figure 8 the effect of cytosolic H+ concentration changes in 
the SNARF emission fractions <590 nm and >590 nm are shown. With the program ImageJ 
and the plugin “ratioplus”, a ratio signal from the <590 nm and the >590 signal was formed. 
Drifts that are present in the single fractions are almost absent from the ratio signal. To measure 
the H+ kinetics, the ratio signal was noise filtered with a low pass filter and a threshold of 0.012 
Hz. From this noise filtered signal, the derivative with respect to the time was formed with the 
program clampfit (Axon Instruments). 
The dye was applied as membrane permeable ester (acetoxymethyl ester: AM) to the cells. In 
the cytosol unspecific esterase did cleave the ester from the fluorescent molecule, leaving a 
carboxyl group that gave a charge to the dye (Figure 7). As a consequence, SNARF was 
trapped inside the cell. The cardiomyocytes were stained with imaging solution (Table 6) 
containing 50-100 µM SNARF for 10-15 min at room temperature in the setup. Due to staining 
in the bath chamber, it was possible to take snapshots from time to time and thereby follow the 
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staining. For pH measurements, SNARF was excited with the 555 nm laser. The scanning 
frequency was 0.2 Hz.  
For pH imaging experiments, liberated cardiomyocytes were produced as described under 
cardiomyocytes isolation and cultivation (p.24). Experiments to measure the lactate induced 
acidification were performed at the day of preparation within 2-3 h after the animal had been 
sacrificed.  
 
 
The solutions used for pH imaging experiments were based on the Yog-Mod solution from the 
cardiomyocyte isolation procedure since the cells remained viable in that environment. For the 
composition of HEPES-only-buffered solution see Table 6. For CO2-buffered solution, 26 mM 
of NaCl of HEPES-only-buffered solution were substituted by 26 mM NaHCO3 and the solution 
was gassed with carbogen (95% O2 + 5% CO2). For lactate-, NH4Cl- and high K+-containing 
solutions, NaCl was substituted in the adequate amount. For 0 Na+-solution, NaCl was 
substituted by NMDG (N-Methyl-D-glucamin) and HCl. The pH of all solutions was, if not 
mentioned otherwise, adjusted to 7.4. 
All inhibitors used were dissolved in DMSO (Table 5). All experiments were performed at room 
temperature. 
Figure 8 SNARF recordings 
The emission spectrum of SNARF-5F, excited at 555 
nm, was split into a fraction shorter than 590 nm (purple) 
and longer than 590 nm (red). The signals of both 
fractions were used to form the ratio (black), which was 
converted to H+ concentrations according to the 
calibration (Figure 9). For the analysis of [H+]i changes 
per time, the derivative of the calibrated ratio signal with 
respect to the time was used (blue). 
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2.2.1.2 Calibration (SNARF) 
 
To convert the ratiometric imaging data to pH or H+ concentration values, the system had to be 
calibrated. This was done with the help of nigericin (Sigma-Aldrich), which is an antibiotic that 
incorporates into the cell membrane and shows an H+/K+ exchanger property. The cell 
membrane is anyway permeable for K+ due to Na+/K+ ATPase and K+ inward rectifier (Zobel et 
al., 2003) activity.  
Therefore, K+ entering or leaving the cell via nigericin together with a proton may just be 
replenished. This means that the intracellular H+ concentration may adjust to the extracellular 
levels without any restriction. By measuring the SNARF ratios at defined extracellular pH (6.0, 
6.5, 7.0, 7.5, and 8.0), calibration curves for H+ and pH calibration were produced (see Figure 
9).  
The equation describing the fit was determined to be: Y= 44.851 X0.1368. Y stands for the ratio 
values measured with SNARF, whereas x stands for the H+ concentration. For the pH imaging 
experiments, only y is known. To know X, the formula had to be converted: X = 
(Y/44.851)(1/0.1368). Then, all SNARF ratio values were converted according to this equation to 
H+ concentration values. 
The medium used for the calibration was HEPES-only-buffered solutions as described above, 
containing 20 mM HEPES instead of 5 mM. NaCl was substituted with KCl (130 mM) to mimic 
intracellular K+ levels. The pH was adjusted with NaOH. 
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Figure 9 Calibration of the SNARF-imaging setup 
 
A Recording of the calibration procedure. B Calibration curves H+ and pH calibration. The exponential fit for H+ 
calibration can be described by the following equation: Y = 44.851 X0.1368. The linear fit for pH calibration is 
described by the following equation: Y =-0.2404 X + 1.9758.  Errors are shown as standard error. 
 
A 
B 
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2.2.1.3 Determination of H+ buffer capacity and acid/base flux  
 
The cytosolic H+ buffer capacity was determined by the use of butyric acid. In an aqueous 
environment, the acid will be in an equilibrium of its acid [HBut] and base equivalent [But-]. This 
equilibrium is described by the Henderson-Hasselbach- Equation: 
 (1) pH = pKs + log ([But-])/ [HBut]) 
As butyric acid is membrane permeable (Walter and Gutknecht, 1984) it can enter the cell 
independent of membrane transporters. Because the bath chamber is continuously perfused, 
its volume can be considered as infinite. Therefore, [HBut]i is assumed to be equal to [HBut]o. 
Based on this assumption and the Henderson-Hasselbach-Equation, the cellular H+ buffering 
capacity was determined. The pKs value for butyric acid is known to be 4.82 (German Wikipedia, 
14.10.2013) and the extracellular pH was set to a known value (pH 7.4). As a defined 
concentration of sodium butyrate [NaBut] was used (1 mM), the concentration of undissociated 
acid in medium and cytosol, was calculated with the Henderson-Hasselbach-Equation: 
(2) 7.4 = 4.82 + log (([NaBut] – [HBut])/ [HBut]) 
(3) 7.4 = 4.82 + log ((1 mM– [HBut])/ [HBut]) 
(4) [HBut] = 0.00262337 mM 
With H+ imaging, the minimal cytosolic pH during extracellular application of HBut (0.00262337 
mM) was determined. By the use of the Henderson-Hasselbach-Equation [But-] was determined 
for the minimal pH (for example, the minimal pH reaches 7.3): 
(5) 7.3 = 4.82 + log ([But-]/ 0.00262337 mM) 
(6) 107.3-4.82 = [But-]/ 0.00262337 mM 
(7) 0.79 mM = [But-] 
This means that the extracellular application of sodium butyrate (1 mM) resulted in a cytosolic 
But- concentration of 0.79 mM at the maximal acidification. In addition, the cytosolic H+ load or 
pH change was measured to be 5.82 nM or ∆ pH 0.0535 (at a basal [H+]i of 44.4 nM). Since 
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each But- formation must go along with one H+ release, the cytosolic H+ content was increased 
by 0.79 mM. The ratio of the cytosolic H+ load (here 0.79 mM) and the change of free cytosolic 
H+ (here 5.82 nM) is the so called buffer ratio (ρ): 
(8) ρ = ∆ [But-]i / ∆ [H+]i 
ρ = 135,738.83 
The ratio of the cytosolic H+ load and ∆ pH is the so called buffer capacity (β): 
(9) β = ∆ [But-]i / ∆ [pH]i 
β = 14.77 mM 
If the cytosolic ability of H+ buffering is known, the acid/base flux (JA/B) can be calculated. To do 
this, the measured kinetics of cytosolic H+ concentration or pH changes were multiplied with ρ 
or β, respectively. ρ was found to depend on [H+]i in an exponential manner. Therefore, an 
additional possibility to determine JA/B is the use of the fit describing the relation of ρ and [H+]i. 
To do so, the SNARF measurement was calibrated in H+ and noise filtered. Then, its first 
derivative with respect to the time was formed with clampfit (Figure 8). Next, the H+ calibrated 
recording was converted to a buffer ratio recording with the fit describing the relation of ρ and 
[H+]i and was named “adaptive buffer ratio”. Then, the derivative was multiplied with the 
adaptive buffer ratio. The resulting trace is JA/B per time. The maximal fluxes per application 
were analysed. 
2.2.1.2 H+ imaging (Fluorescein-DHPE) 
 
Fluorescein-DHPE (N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine; Invitrogen) is a pH sensitive fluorescent dye that contains a lipophilic 
part that incorporates into cell membranes (Figure 10).  
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Figure 10 Chemical structure of Fluorescein DHPE (modified from Invitrogen) 
The fluorescein is shown in black. The 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DHPE) is 
shown in red. 
 
The measurements were performed with the LSM 700. The dye was excited with the 405 nm 
and the 488 nm laser, which allowed ratiometric imaging or with the 488 nm laser alone. 
Application of the 405 nm laser was problematic, since the used contraction inhibitor 
blebbistatin shows fluorescence when it is excited with the 405 nm laser. Since blebbistatin 
showed a different bleaching behaviour than Fluorescein-DHPE, ratio metric measurements 
did tend to have a strong drifting. Before cells were loaded with the dye, blebbistatin had to be 
bleached until no further bleaching was observed. Since bleaching may be phototoxic to the 
cells, this procedure is far from being ideal. An additional problem in ratio metric imaging with 
Fluorescein-DHPE was the scanning nature of the microscope. The picture will be generated 
by scanning the sample line by line. This is time consuming and therefore limited the maximal 
scanning rate at the used settings to about 1-2 Hz. For ratiometric imaging it is necessary to 
scan each picture twice; once at 405 nm and once at 488 nm excitation. Due to the time needed 
for scanning, the second picture will be delayed and therefore it does not fit exactly. As 
consequence, the noise may become very intense and could even, in extreme cases, 
completely cover the pH signals.  
Even though problematic, the advantages of ratiometric imaging are explained in H+ imaging - 
SNARF (p.35). But the experience gained during this work suggest that Fluorescein-DHPE can 
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be used for ratio metric imaging in the LSM 700, but might perform better in a non-scanning 
system. 
Calibration for Fluorescein-DHPE measurements was performed by application of HEPES-
only-buffered solutions (Table 6), containing 50 mM HEPES instead of 5 mM, that had been 
adjusted to a defined pH. The strong buffering should force the cell surface pH to the defined 
pH of the applied solution.  
 
2.2.2 Lactate imaging 
2.2.2.1 Transduction 
 
For lactate imaging, cardiomyocytes were prepared as described under “cardiomyocyte 
isolation and cultivation” (p.24) until step 22. Per batch, 6 petri dishes were settled with 
cardiomyocytes. After cell settlement, the 50 µl drop was removed from the petri dish to avoid 
a waste of virus on unattached cells. Next, 5 µl of an adenovirus-stock (4.8 x 1010 PFU; Vector 
Biolabs), containing the FRET-based lactate sensor Laconic (Lactate optical nano indicator 
from CECs; San Martin et al., 2013), were mixed with 95 µl of ITS-medium. The lactate sensor 
is based on LldR, a transcription regulating protein from Escherichia Coli that performs a 
conformation change upon lactate binding (Aguilera et al., 2008). San Martin et al. (2013) took 
advantage from this feature and combined it with the fluorescent proteins mTFP and Venus. 
Those Fluorescent proteins change their distance when the LldR binds lactate, which results in 
an altered FRET-signal.  
According to Du et al. (2004), murine and human cardiomyocytes transduce best with serotype 
1 adenovirus, but the here used serotype 5 did also work. On 4 petri dishes 25 µl of virus-
containing ITS-medium were added each. The remaining 2 petri dishes were covered with 25 
µl ITS-medium each as control. After 2 h incubation at 37°C/ 5% CO2, the petri dishes were 
filled up with 2 ml ITS-medium each. After 2 days of cultivation, the medium was exchanged 
with fresh ITS medium, lacking blebbistatin. This was necessary because blebbistatin produced 
some fluorescence (also described by Lucas-Lopez et al., 2005) when excited with the 405 nm 
Laser. Interestingly, at this stage of cultivation, the absence of a contraction inhibitor did not 
seem to affect the cell viability or shape. 
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2.2.2.2 Lactate imaging 
 
Figure 11 Expression of Laconic in mouse cardiomyocytes 
A Isolated cardiomyocytes 3 d after transduction. B Fluorescence properties of Laconic, as determined with the 
λ-stack function of the LSM 700. The total emission spectrum of Laconic when excited with 405 nm is shown in 
black. The emission spectrum of Laconic when only the Venus is excited with 488 nm is shown in yellow. The 
emission spectrum of mTFP when excited with 405 nm is shown in cyan. The dotted line indicates the used 
splitting point of CFP and YFP signal at 508 nm. 
 
Transduced cardiomyocytes were used 3-4 d after transduction. The imaging experiments were 
performed with a ZEISS LSM 700 confocal microscope. For setup details see Figure 5. To 
induce FRET in the lactate sensor Laconic, the mTFP (CFP variant; see Ai et al., 2006) was 
excited with a 405 nm laser. To determine the optimal splitting point of the emission spectrum 
in mTFP and Venus (YFP variant) dominated fractions, the total emission spectrum of Laconic, 
when excited with 405 nm and the Venus spectrum alone, when excited with 488 nm were 
recorded (Figure 11).  
  
A B 
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Figure 12 Example recording of lactate imaging in cardiomyocytes with Laconic 
The ratio is shown in black whereas the mTFP fraction is shown in cyan and the Venus fraction is shown in 
yellow. 
 
Accordingly, the Laconic emission spectrum was split at 508 nm. The resulting mTFP and 
Venus signals could be used for ratio metric imaging, due to their contrary behaviour on lactate 
concentration changes. Since lactate binding will increase the distance of mTFP and Venus, a 
rise in cytosolic lactate concentration will increase the mTFP signal but decrease the Venus 
signal (Figure 12). 
The same solutions as described for SNARF measurements were used (Table 6). 
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2.2.3 Pyruvate imaging 
 
The cardiomyocytes were isolated and transduced as described for the lactate sensor. The 
pyruvate sensor is described by San Martin et al. (2014). Similar as for the lactate sensor 
Laconic, a transcription regulating protein was used. PdhR, a pyruvate binding protein, from 
Escherichia Coli was combined with mTFP and Venus and called Pyronic (pyruvate optical 
nano indicator from CECs). The used imaging setup and settings were the same as for lactate 
imaging.  
For pyruvate-containing solutions, NaCl was substituted by NaPyruvate in imaging solution.  
2.2.4 Statistical analysis 
 
The calibrated SNARF recordings were analysed with the program clampfit (Axon Instruments). 
Marco Alt found its suitability for analysis of imaging data (Stridh et al., 2012). To determine the 
H+ or pH kinetics, derivatives with respect to the time of the calibrated recordings were produced 
with clampfit. Because the noise was faster than the signals, the noise was reduced with a 
noise filter at a threshold of 0.012 Hz in clampfit, before the derivatives were calculated. The 
resulting trace showed ∆[H+]i/∆t or ∆[pH]i/∆t, depending on the calibration. The Laconic and 
Pyronic recordings were treated in the same way. The maximal kinetic during an application 
was measured. Significance was tested with paired or unpaired students’t tests (P ≤ 0.05 *, P 
≤ 0.01 **, P ≤ 0.001 ***).  
2.3 Western blot 
1. Lysate preparation  
Tissue samples were transferred to 1.5 ml centrifugation tubes and covered with 4% 
SDS (sodium dodecyl sulfate; MP Biomedicals), containing protease inhibitor (Roche 
product number 11836170001). Then, lysate was produced by ultrasonic treatment 
(30s). To remove particles and jellylike remnants, samples were centrifuged at 14,000 x 
g for 5 min and only the supernatant was kept for experiments. Cell culture samples 
were collected in 4% SDS containing protease inhibitor and transferred to 1.5 ml to 
centrifugation tubes. Jellylike remnants were dissolved by scratching the tube several 
times across the rack for 1.5 ml tubes. For cardiomyocyte samples, liberated 
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cardiomyocytes were centrifuged for 5 min at 14,000 X g, the supernatant was removed 
and the pellet was covered with 4% SDS, containing protease inhibitor. Finally the tube 
was vortex treated to dissolve the pellet. Lysates from MCT1 or MCT2 expressing 
Xenopus laevis oocytes were provided by Michael Klier and Christina Schüler, 
respectively. 
  
2. Determination of protein concentration 
The protein concentration of the samples was determined with the bicinchoninic acid 
(BCA) -test (Pierce® BCA Protein Assay Kit Thermo scientific 23225) and an ELISA 
reader.  
3. Gel electrophoresis 
For gel electrophoresis, samples were prepared in the following manner: Total 
volume(sample electrophoresis) = volume tissue sample(20 µg protein; 65% of total volume) + volume 
sample buffer (Invitrogen NP0007)(25% of total volume) + volume reducing agent (Invitrogen 
NP0004)(10% of total volume). Accordingly, the total volume(sample electrophoresis) was calculated 
as follows: Volume tissue sample(20 µg protein; 65% of total volume) / 0.65. Ready–to-use 
polyacrylamide gels from Invitrogen or Expedeon were used. As protein size indicator, 
10 µl of the Novex® Sharp Protein Standard (Invitrogen LC5800) was added per gel. 
For the electrophoresis, the device provided by Invitrogen (XCell SureLock™ Mini-Cell 
EI0001) was used. The outer chamber was filled with 600 ml 1x MOPS buffer (Invitrogen 
NP0001), whereas the inner chamber was filled with 200 ml 1 x MOPS buffer (Invitrogen 
NP0001), containing 500 µl NuPage antioxidant (Invitrogen NP0005). The gel was 
started with 100 V and a security threshold of 60 mA for 10 min and then continued for 
50 min with 200 V and a security threshold of 120 mA.  
4. Western blot 
The western blot was performed with the device from Invitrogen (XCell SureLock™ Mini-
Cell + XCell II™ Blot Module). As blotting solution, 300 ml NuPAGE® Transfer Buffer 
(Invitrogen LC2000), containing 30 ml methanol and 300 µl NuPage antioxidant 
(Invitrogen NP0005), was used. Sponge pads and nitrocellulose membranes (Invitrogen 
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LC2006) were incubated for approximately 30 min in blotting solution before they were 
used. When membrane, gel and sponge pads had been transferred to the blotting 
chamber, the latter one was incorporated into the XCell SureLock™ Mini-Cell 
(Invitrogen) and filled with blotting solution. The outer chamber was filled with distilled 
water for cooling. The blotting was performed at 60 V for 100 min. 
5. Protein detection 
The protein detection was performed with HRP (horse radish peroxidase)-labelled 
secondary antibodies and luminol based luminescence. First, the membrane was briefly 
incubated in Ponceau staining (Sigma Aldrich), which gives a red staining to any kind of 
protein, to check if the blotting had worked properly. Second, the membrane was 
incubated for 1 h in blocking solution (Table 8) at room temperature. Then, primary 
antibody was added to the blocking solution. For antibody details see Table 9. The 
primary antibody was incubated for 2 h at room temperature. Then, the blocking solution 
was removed and the membrane was washed for 30 min in distilled water. The 
secondary, HRP-labelled antibody was applied to the membrane, diluted in blocking 
solution and incubated for 1 h at room temperature. To finish, the secondary antibody 
was removed and the membrane was washed for 30 min in distilled water. 
6. HRP signal recording 
The luminescence was induced by application of 500 µl LumiGlo (Cell Signalling #7003) 
to the blot. The signal was recorded with a Biorad imager. 
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Table 7 Recipe of TBST 
The pH was set to 7.5 with NaOH 
Chemical Concentration 
Tris-HCl (Carl Roth) 50 mM 
NaCl  (Carl Roth) 150 mM 
Tween20 (Sigma Aldrich) 1‰ 
 
Table 8 Recipe of western blot blocking solution 
Chemical Concentration 
TBST 1x 
BSA (Sigma Aldrich) 1% (w/v) 
Casein (Sigma Aldrich) 0.5% (w/v) 
 
Table 9 Antibodies used for western blot 
Primary antibody  Concentration/ 
dilution used 
Secondary 
antibody  
Dilution 
used 
CAII (Millipore AB1828) 50 µg/ml anti-rabbit (Santa 
Cruz  sc-2004) 
1:1000 
CAIII (Santa Cruz sc-50715) 4 µg/ml anti-goat (Santa 
Cruz  sc-2020) 
1:1000 
CAIV (R&D AF2414) 0.8 µg/ml anti-goat (Santa 
Cruz  sc-2020) 
1:1000 
CAXIV (Santa Cruz sc-25602) 50 µg/ml anti-rabbit (Santa 
Cruz  sc-2004) 
1:1000 
MCT1  (Millipore AB3538P) 2 µg/ml anti-chicken (Santa 
Cruz  sc-2428) 
1:1000 
MCT2  (Millipore AB3542P) 1:500 anti-rabbit (Santa 
Cruz  sc-2004) 
1:1000 
NBCe1 (Abcam ab78326) 1:500 anti-rabbit (Santa 
Cruz  sc-2004) 
1:1000 
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2.4 Immunohistochemistry 
 
Tissue sections (10 µm) were produced with a cryostat at -20°C. The sections were mounted 
on coated glass slides (Superfrost ultra plus; Thermo scientific) and fixed with acetone for 5 
min in humid chamber at room temperature. Isolated cardiomyocytes (for procedure see p.24), 
settled on matrigel coated petri dishes could not be fixed with acetone, since the used petri 
dishes were made of plastic sensitive towards acetone. Isolated cardiomyocytes were therefore 
fixed for 5 min at room temperature with the fixing agent Histofix (Roth). After fixation, the 
samples were briefly washed in PBS (phosphate-buffered saline: 130 mM NaCl, 7 mM 
Na2HPO4, 3 mM NaH2PO4, pH 7.4) to remove fixing agent remnants. Next, the samples were 
incubated in blocking solution (Table 10) for 1h at room temperature. After blocking, primary 
antibody was added to the blocking solution and incubated for 2 h in a humid chamber at room 
temperature (for detail information see Table 11). Then the antibody solution was removed and 
the samples were washed for 30 min at room temperature. Secondary antibody, carrying a 
fluorescent molecule (Alexa Fluor 488 or Alexa Fluor 546) was applied to the samples, diluted 
1:1000 in blocking solution, together with the fluorescent DNA staining agent Hoechst 33342 
(16 µM; Life technologies). Finally, the samples were washed for 30 min in PBS. Pictures were 
taken the same day with the Zeiss LSM 700 confocal microscope. 
Table 10 Recipe of blocking solution for immunohistochemistry. 
If a secondary antibody directed against goat was used, goat serum was replaced by donkey 
serum. The solution was adjusted to pH 7.4 
Chemical Concentration 
NaCl (Carl Roth) 130 mM 
Na2HPO4 (Riedel de Haёn) 7 mM 
NaH2PO4 (Riedel de Haёn) 3 mM 
BSA (Sigma Aldrich) 3% (w/v) 
TritonX100 5‰ 
Goat serum (or donkey serum) 
(Sigma Aldrich) 
1% (v/v) 
 
Table 11 Antibodies used for immunohistochemistry. 
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Secondary antibodies were all bought at Invitrogen. 
Primary antibody  Concentration 
used 
Secondary antibody  dilution 
used 
CAII (Millipore AB1828) 50 µg/ml anti-rabbit (A-11008) 1:1000 
CAIII (Santa Cruz sc-50715) 4 µg/ml anti-goat (A-11055) 1:1000 
CAIV (R&D AF2414) 0.8 µg/ml anti-goat (A-11055) 1:1000 
CAIX (Novus biologicals 
NB100-417) 
8 µg/ml anti-rabbit (A-10040 and A-
11010) 
1:1000 
CAXIV (Santa Cruz sc-
25602) 
50 µg/ml anti-rabbit (Santa Cruz  sc-
2004) 
1:1000 
MCT1  (Millipore AB3538P) 4 µg/ml anti-chicken (A-11039) 1:1000 
MCT4 (Millipore AB3314P) 4 µg/ml anti-rabbit (A-11008) 1:1000 
Slow myosin (Millipore 
MAB1628) 
4 µg/ml anti-mouse (A-10036) 1:1000 
 
2.5 Genotyping of KO animals 
NBC KO 
The animals were produced and described by Gawenis et al. (2007). Exon 9 is disrupted. 
CAII KO animals 
The CAII KO animals used were produced and described by Lewis et al. (1988). The loss of 
CAII activity is based on a point mutation in codon 155 if counted from the start codon at position 
110 in exon 1 of the gene car2. The codon CAA is changed to TAA, which is a stop codon (Pan 
et al., 2006). 
CAIV KO 
The animals were produced and described by Shah et al. (2005). Exons 1b, 2 and 3 as well as 
parts of exon 4 were deleted. 
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CAIX KO 
The animals were described by Gut et al. (2002). The enzyme function was disrupted by 
insertion of a DNA sequence into exon 1.  
CAXIV KO 
The animals were produced and described by Shah et al. (2005). Exon 4 was deleted. 
 
1. DNA-Purification  
 
A. Tissue sample (ear) got digested in 500 µl Lysisbuffer (Table 13) at 55°C for 3 h  
B. Enzymes were heat inactivated (20 min; 95°C) 
C. Undissolved parts were removed by centrifugation (15 min 19000 x g) 
D. Supernatant was mixed 1:1 with isopropanol and incubated for 20 min at RT 
E. Centrifugation for 15 min at 19000 x g 
F. supernatant was removed and 500 µl 70% EtOH was added to separate DNA from 
contaminants (like proteins) 
G. Centrifugation (like E) 
H. EtOH was removed and the tubes were dried at 78°C (10-20 min) 
I.  DNA was dissolved in 100 µl TE-buffer (Table 12) 
 
2.1 PCR – CAII KO 
A. The protocol is a modified version of that one described by Sjöblom et al (2009). 
WT- and KO-PCR master mix were prepared (per reaction: 10 µl Ready-Mix 
(Sigma); 1 µl 10 µM reverse primer ( CAII r); 1 µl 10 µM forward CAII (WT) 
respectively forward CAII (KO); 3 µl DNA-free H2O). For primer see Table 14 .  
B. 5 µl DNA-sample (dissolved in TE-buffer) was added per reaction 
C. PCR was performed in a thermo cycler (95°C for 60 s53°C for 30s 72°C for 30s; 
35 cycles  72°C for 10 min) 
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2.2  PCR – CAIV (the genotyping was performed by Ivan Ruminot) 
 
2.3  PCR – CAIX KO  
A. WT- and KO-PCR master mix were prepared (per reaction: 10 µl Ready-Mix 
(Sigma); 1 µl 10 µM reverse primer ( CAIX r); 1 µl 10 µM forward CAIX (WT) 
respectively forward CAIX (KO); 3 µl DNA-free H2O). For primer see Table 14. 
B. 5 µl DNA-sample (dissolved in TE-buffer) was added per reaction 
C. PCR was performed in a thermo cycler (94°C for 90s 61°C for 60s 56.5°C for 
60s 72°C for 30s; 35 cycles 72°C for 10 min) 
 
 
Figure 13 Genotype determination of CAII +/-, 
CAII +/+ and CAII -/- mice  
The wild type (WT) and the knock out (KO) 
allele were tested in separate PCR reactions, 
so two PCRs had to be performed per animal. 
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2.4 PCR – CAXIV  
A. WT- and KO-PCR master mix were prepared (per reaction: 10 µl Ready-Mix 
(Sigma); 1 µl 10 µM reverse primer; 1 µl 10 µM forward primer; 3 µl DNA-free 
H2O). For primer see Table 14.  
B. 5 µl DNA-sample (dissolved in TE-buffer) was added per reaction 
C. PCR was performed in a thermo cycler (92°C for 45 s70°C for 30s; 35 cycles 
72°C for 10 min) 
Figure 14 Genotype determination of CAIX +/-, CAIX +/+ and CAIX -/- mice 
The wild type (WT) and the knock out (KO) allele were tested in separate PCR reactions, so two 
PCRs had to be performed per animal. Since the PCR product from the KO allele is bigger than 
that one from the wild type allele (WT 442 bp and KO 562 bp), the two PCR reactions might 
possibly be performed in the same tube, but this was not tested during this work. 
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Figure 15 Genotype determination of CAXIV +/-, CAXIV +/+ and CAXIV -/- mice 
The PCR products from the wild type (WT) and the knock out (KO) allele were differing in size (WT 420 bp and 
KO 400 bp) and therefore just one PCR was performed per animal.   
 
2.5  PCR – NBC KO (the genotyping was performed by Ivan Ruminot) 
3 Gel 
The samples were loaded on a 2.5 – 3% agarose gel, containing 10µl Roti Safe Staining 
(Carl Roth) / 100 ml. The electrophoresis was performed at 100 mV for 15 – 20 min.  
4 Picture 
A pictures of the resulting gels were taken with an imager from INTAS. 
 
Table 12 TE-Buffer 
The pH was adjusted to 7.5 
Chemical Concentration 
Tris-HCl (Carl Roth) 10 mM 
EDTA (Sigma 
Aldrich) 
1 mM 
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Table 13 Lysis buffer 1x MGB (Modified Gitschier Buffer) 
Chemicals Concentration 
Tris (Carl Roth) 67 mM 
(NH4)2SO4 17.7 mM 
MgCl2 6.5 mM 
TritonX-100 5‰ 
Proteinase K (Carl Roth) 1 µg/µl 
 
Table 14 Further materials used for genotyping 
Material 
Isopropanol 
70% Ethanol 
Roti-Safe GelStain (Carl Roth) 
Triton X 
Primer- NBC KO 
Forward Primer 
5’TCACAAACCTTTCAGCAAAAGAGTGC3’ 
Reverse Primer 
5’CAAAGAGCAACAGTCAGACAGC3’ 
Primer- CAII KO 
Forward primer f CAII (WT): 
5’GATTGGACCTGCCTCAC3’ 
Forward primer f CAII (KO): 
5’GATTGGACCTGCCTCAT3’ 
Reverse Primer CAII : 5’TACCTCCGGTAAACTGTTC3’ 
Primer- CAIX KO 
Forward primer (WT): 
5’CTCCTATTTCCGATGCACGTACAG3’ 
Forward primer (KO): 
5’AGGAGCAAAGCTGCTATTGG3’ 
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Reverse primer: 
5’CTTACCTGAGCCTAGATTTGGAAG3’ 
Primer- CAXIV KO 
Forward primer: 
5’AGGCTCCTGCAGCTAAGGTGGGATCAGACG3’ 
Reverse primer: 
5’TCCATCCTCTGAGCTCCACTGGACCGAACC3’ 
Primer- CAIV KO 
CA4K/OE25 5’ 
5’CACCCTTCATCCTCGTCGGCTATGACCAAAAG
C3’ 
 
CA4/OIntron1A 5 ‘ 
 
5’TGAGGTCAATTCCCAGCTCCCACATTGTTGC3’ 
 
CACCCTTCATCCTCGTCG
CA4K/OExon6 3’ 
5’TGTGGATCTTGATGGGTTGTTTGTACACAGTCC3’ 
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3. RESULTS 
3.1 Buffer capacity and buffer ratio in ventricular mouse cardiomyocytes 
 
The buffer capacity (β) and buffer ratio (ρ) were determined by SNARF imaging (Figure 16). In 
HEPES-only, CO2/HCO3- and CO2/HCO3--buffered solution plus EZA (30 µM). NaButyrate was 
applied to the cells at a concentration of 1 mM. The pH of the solutions was set to pH 7.4 and 
the concentration of butyric acid was calculated, as explained in the Materials & Methods part. 
The intracellular concentration of butyric acid was assumed be the same as outside. According 
to the Henderson-Hasselbach equation, the intracellular butyrate concentration at [H+]i,max was 
calculated.  
 
Figure 16 Determination of β and ρ in mouse cardiomyocytes 
The ability of mouse cardiomyocytes to buffer H+ was determined by pH imaging with SNARF. NaButyrate was 
applied to the cells at a concentration of 1 mM in HEPES-only, CO2/HCO3- and CO2/HCO3--buffered solution plus 
30 µM EZA. The hereby caused intracellular changes in H+ concentration are shown in red. One particular example 
trace is shown.  
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The averaged values for ρ are named fixed buffer ratio (ρfixed) to distinguish it from the 
adaptive buffer ratio (ρadap.). β and ρ are shown in Figure 17 and Table 15. 
 
 
Figure 17 Buffer capacity (β) and fixed buffer ratio (ρfixed) in mouse cardiomyocytes 
The buffer capacity and fixed buffer ratios were determined for the HEPES-only-, CO2/HCO3-- and CO2/HCO3--
buffered + EZA (30 µM) conditions. For the values see Table 15. 
 
Table 15 Buffer capacity (β) and fixed buffer ratio (ρfixed) in mouse cardiomyocytes 
Buffering conditions β (mM) ρfixed*10-4 
HEPES-only 8.8 ± 0.75 5.6 ± 0.89 
CO2/HCO3- 30.2 ± 2.9 17.67 ± 1.98 
CO2/HCO3- + EZA (30 µM) 13.1 ± 0.88 9.6 ± 1.4 
 
The individual buffer ratios and buffer capacities were plotted against the individual basal [H+]i 
and pH, respectively (Figure 18). The dependence of the buffer ratio on [H+]i is described by an 
exponential fit, that increases when [H+]i drops. The correlation between pHi and buffer capacity 
is not obvious. Linear fits revealed a slight tendency for the buffer capacity to increase with the 
pHi. The equations of the fits, describing the correlation of [H+]i and ρ are ρadap.HEPES = [H+]i-
1.5572
*4.43774*107, ρadap.CO2/HCO3-  = [H+]i-1.16741*2.45908*107 and ρadap.CO2/HCO3- + EZA   = [H+]i-
2.13811
*5.34228*108. 
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Figure 18 Impact of basal pH on buffer ratio and buffer capacity 
A Relation of basal cytosolic H+ concentration and the buffer ratio in HEPES-only-buffered solution (fit: buffer ratio= 
[H+]i-1.5572*4.43774*107). B Relation of basal cytosolic H+ concentration and the buffer ratio in CO2/HCO3--buffered 
solution (fit: buffer ratio= [H+]i-1.16741*2.45908*107) C Relation of basal cytosolic H+ concentration and the buffer 
ratio in CO2/HCO3--buffered solution in the presence of the CA inhibitor EZA (fit: buffer ratio= [H+]i-
2.13811
*5.34228*108). D relation of basal cytosolic pH and the buffer capacity in HEPES-only-buffered, CO2/HCO3-
-buffered and CO2/HCO3--buffered in the presence of EZA (30 µM). The values in A-C were fitted with an 
exponential, asymptotic fit in origin. 
 
 
 
A B 
C D 
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3.2 pH regulating proteins and lactate transporter present in mouse 
cardiomyocytes 
3.2.1 Carbonic anhydrase in ventricular mouse cardiomyocytes 
 
The enzymatic activity of cytosolic carbonic anhydrase (CA) was tested by application of 
CO2/HCO3--buffered solution in absence and presence of the CA inhibitor EZA. The scheme of 
CO2-dependent pH changes is shown in Figure 19 A including the potential role of cytosolic 
carbonic anhydrase. Although the conversion of H2O + CO2 to H+ + HCO3- takes place 
spontaneously, cytosolic CA may speed up this process (Stridh et al. 2013). In ventricular 
mouse cardiomyocytes from WT animals, application of the CO2/HCO3- caused a ∆[H+]i/∆t of 
24.5 ± 2.5 nM/min in the absence and 24.7 ± 2.8 nM/min in the presence of EZA (30 µM) (Figure 
19). The ∆[H+]i/∆t during removal of extracellular CO2/HCO3- was determined to be  
-24.9 ± 2.8 nM/min in WT and -38.7 ± 6.7 nM/min in CAII-/- animals. The unpaired student’s 
ttest revealed a P of 0.087, thus the difference was not significant. The ∆[H+]i/∆t during 
reintroduction of extracellular CO2/HCO3- was determined to be 28.1 ± 3.5 nM/min in WT and 
44.5 ± 3.8 nM/min in CAII-/- animals (Figure 20). The unpaired student’s ttest revealed a P of 
0.19, thus the difference was not significant.  
Immunohistochemical approaches to determine CAII’s presence in mouse cardiomyocytes 
resulted in clear and defined fluorescence signals but the same kind of signals were observed 
in CAII knockout animals (Figure 21).   
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Figure 19 Test for cytosolic CA activity  
A Scheme of CO2/HCO3--induced changes of cytosolic pH. B Recordings of cytosolic H+-imaging are shown in 
black. The kinetic of H+ concentration changes is shown in blue. C Statistics of effect by EZA on cytosolic CO2 
induced acidification.  
 
 
B 
A 
C 
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Figure 20 Cytosolic CA activity in WT and CAII-/- cardiomyocytes 
The cytosolic H+ concentration was measured with SNARF in a calibrated system. The cells were alternatively 
perfused with CO2/HCO3- and HEPES-buffered medium (pH 7.4) to measure the CO2 induced cytosolic pH change 
in wild type and CAII KO animals. A Recordings of CO2/HCO3- induced cytosolic H+ concentration changes in wild 
type and CAII KO cardiomyocytes. The kinetic of cytosolic H+ concentration changes is shown below the H+ 
recordings. B Statistics of effect by EZA on cytosolic CO2 conversion.  
 
The loss of CAII activity is based on a point mutation in codon 155 (if counted from the start 
codon at position 110 in exon 1 of the gene car2). The codon CAA is changed to TAA, which is 
a stop codon (Pan et al., 2006). This leads to the possibility that CAII fragments, consisting of 
the enzymes forepart, were present in the cells and detected by the polyclonal antibodies 
(Figure 21). Therefore, western blots were performed to detect CAII in wild type and CAII 
knockout heart samples (Figure 22). In the western blot, no protein was detected by the anti-
CAII antibody in CAII-/- samples.  In the sample from the WT heart, CAII was clearly detected. 
This is most likely caused by the high erythrocyte content in the heart samples which, contain 
CAII (Geers et al., 1992; Poole and Halestrap, 1994).  
A B 
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It was found that the antibody used for CAII detection could also detect the CAIII (Figure 23), 
providing the possibility that the signal observed in Figure 21 results from unspecific binding to 
CAIII.  
Figure 21 Detection of CAII in WT and CAII-/- 
cardiomyocytes 
 A Isolated cardiomyocyte from wild type animal 
(p20, black 6) with identification number 13201. CAII 
was detected with an anti-CAII antibody and is 
shown in green, nuclei were stained with Hoechst 
(blue).  
B PCR product from genotype confirmation of 
animal 13201. Only the wild type allel was detected 
(WT).  
C Isolated cardiomyocyte from CAII-/- animal (p20, 
black 6) with identification number 13208. CAII was 
detected with an anti-CAII antibody and is shown in 
green, nuclei were stained with Hoechst (blue).  
D PCR product from genotype confirmation of 
animal 13208. Only the KO allel was detected (KO).
 
Figure 22 CAII detection in mouse heart with western 
blot 
20 µg of the lysate from WT and CAII-/- (KO) heart were 
loaded on each lane. In the knockout sample no signal 
was observed. 
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The CAIII had been reported to be rather insensitive to inhibition with EZA and its Ki was 
determined to be as high as 60 µM (Geers et al., 1992; Ki value for CAI: 25 nM, Ki value for 
CAII: 8 nM, Brzozowski et al., 2010). Therefore, the absence of an effect by EZA on the 
CO2/HCO3- induced ∆[H+]i/∆t does not exclude the presence of CAIII from the cytosol. 
CAIII’s presence in ventricular mouse cardiomyocytes was tested with an immunohistochemical 
approach in heart tissue (Figure 24).  
As positive control, a cryostat section of the soleus muscle was used for CAIII detection as the 
soleus muscle is known to provide a strong CAIII presence (Shiels et al., 1982). The oxidative 
nature of the shown muscle was confirmed by immunocytochemistry, detecting slow myosin, 
present in oxidative muscle fibres (Figure 24 B). In the mouse heart the CAIII was not detected 
(Figure 24 C). 
 
Figure 24 CAIII in skeletal and heart muscle.  
A  Cryostat section of lower hind limb (p20, black 6 mouse) with CAIII stained green. B CAIII staining (A) stacked 
with slow myosin staining (red; indicates oxidative myocytes). C Cryostat section of mouse heart (p 19, black 6) 
with CAIII stained green (absent) and nuclei were stained with Hoechst (blue). 
Figure 23 CAII antibody detects CAIII 
20 µg of the lysate of Xenopus oocytes 
heterologously expressing CAIII were loaded on the 
gel. The western blot was used for CAII detection. 
The positive signal in oocytes expressing CAIII 
confirmed the unspecific binding of the CAII antibody 
to CAIII. 
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Extracellular CA activity was measured by alternating application of HEPES-only and 
CO2/HCO3--buffered solution in absence and presence of the CA inhibitor EZA. Figure 25 A, 
the scheme of this experiment is shown. The circle is meant to mimic a cell. Above this cell, an 
example trace of an H+ imaging experiment from the cell surface is shown. During this 
recording, CO2/HCO3- were applied and removed again. When HCO3- reaches the cell surface, 
it will be partially converted to CO2 and water. Hereby it will bind protons, so that the H+ 
concentration at the cell surface drops. The speed of this pH change is dependent of pH 
regulatory mechanism, like carbonic anhydrase (CA). 
This is the same protocol as used for the cytoplasmic CA activity. To measure the cell surface 
pH, the pH sensitive fluorescent dye Fluorescein-DHPE was used. In contrast to the 
experiments performed with the cytosolic pH sensor SNARF, in measurements of the pH on 
the cell surface with DHPE fluorescein, the application of the CA inhibitor EZA reduced the 
∆[H+]o/∆t during CO2/HCO3- application by 53.2% and the ∆[H+]o/∆t during CO2/HCO3- removal 
was reduced by 48% (Figure 25).  
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Figure 25 Activity of extracellular CA on mouse cardiomyocytes  
A Scheme of CO2/HCO3- induced changes of surface pH B Recordings of H+-imaging that were noise filtered Hz 
(black).  The kinetics of surface H+ concentration are shown in blue. C Statistics of the EZA effect on ∆[H+]o/∆t.  
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The origin of this extracellular CA activity was further investigated by protein detection 
techniques. Candidates for extracellular CAs were CAIV, CAIX and CAXIV as they were found 
to be present in mouse cardiomyocytes by Scheibe et al. (2006).  
Immunohistochemical approaches revealed CAIV signals in the ventricle of the mouse heart in 
acetone fixed cryostat sections, that were absent from CAIV KO animals (Figure 26). Western 
blots for CAIV detection in heart samples confirmed CAIV’s presence in the mouse heart 
(Figure 26 B). But immunocytochemistry for CAIV detection in dissociated myocardial tissue 
suggests the origin of those signals in other cell types than cardiomyocytes (Figure 26 A). 
In this work it was not achieved to characterize those CAIV positive cells. Since the murine 
heart is reported to consist of about 30% fibroblasts (Banerjee et al., 2007), those might be 
likely candidates. Sender et al. (1998) did report CAIV signals in endothelial cells and 
cardiomyocytes.  
 
 
Figure 26 CAIV in mouse heart  
15 µM cryostat sections of wild type (A) and CAIV KO (B) mice from the same litter (p20) were used for CAIV 
detection. A Ventricular cryostat section of a p20 WT mouse. B Ventricular cryostat section of a p20 CAIV-/- mouse. 
The CAIV is labelled green. The nuclei were labelled with Hoechst and are shown in blue.  
A B 
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The CAIX was also detected in the mouse heart and stomach with immunohistochemistry, but 
the same positive signals were observed in CAIX KO animals (Figure 28). So the used 
immunohistochemical approach for CAIX detection in mouse heart was not reliable. 
 
  
Figure 27 CAIV detection in dissociated heart sample 
A Dissociated cardiomyocytes and unidentified CAIV positive cells (arrow head). CAIV is shown in green, nuclei 
were stained with Hoechst and are shown in blue. B Western blot against CAIV on myocardial tissue lysates. 20 
µg protein were loaded per lane. Two lanes were loaded with the same sample. P20 wild type black-6 mice were 
used for this experiment 
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Figure 28 CAIX in mouse heart and stomach 
A Cryostat section from wild type (WT) heart (p20, black 6). CAIX is shown in red and nuclei are shown in blue. 
B isolated cardiomyocytes from the ventricle (p20, black 6). CAIX detection is indicated in green, nuclei were 
stained with Hoechst (blue). C Cryostat section from CAIX KO stomach (p34, CAIX-/-). CAIX is shown in red. D 
Cryostat section from wild type (WT) stomach (p21, black 6). CAIX is shown in red. 
 
A B 
C D 
WT WT 
CAIX KO WT 
KO 
stomach  stomach  
heart  cardiomyocyte 
71 
 
 
3.2.2 Lactate transporter in mouse cardiomyocytes 
 
The lactate transport into cardiomyocytes is reported to be mediated by MCTs 
(monocarboxylate transporters) (Halestrap and Meredith, 2004; Koehler-Stec et al., 1998; 
Vinnakota et al., 2011). Those will transport lactate along with one H+. The mainly described 
MCT in the heart is the MCT1 (Bonen et al., 2001; Garcia et al., 1995; Halestrap et al., 1997; 
Jackson et al., 1997).  
The presence of the MCT1 in mouse cardiomyocytes was first tested by protein detection 
(western blot and immunohisto- and immunocytochemistry; Figure 29). The protein was 
detected in western blot of heart samples in four biological replicates (just one is shown; Figure 
29 D). Since erythrocytes could not completely be removed from the sample 
immunocytochemistry detection in dissociated cardiomyocytes (Figure 29 C) was performed 
and confirmed the presence of MCT 1 in ventricular mouse cardiomyocytes. 
To test for a potential involvement of MCT2 in lactate uptake by ventricular mouse 
cardiomyocytes, the myocardial presence of the transporter was tested with western blot 
(Figure 29 E). As control, samples of Xenopus oocytes, heterologously expressing MCT2, were 
added to the blot. In three biological replicates (just one is shown) no positive signal for MCT2 
was found in mouse heart samples, suggesting its absence from cardiomyocytes. 
The presence of the MCT4 in the mouse heart was tested by immunohistochemistry Figure 29 
A). As control, cryostat sections of the lower hind limb of the mouse, containing the oxidative 
soleus muscle and the glycolytic gastrocnemius, were used (Figure 29 B). Since white, 
glycolytic muscle fibres are reported to show a high MCT4 content whereas red, oxidative 
muscle fibres are reported to rather contain MCT1 (Fishbein et al., 2002; Pilegaard et al., 1999; 
Wilson et al., 1998), tissue sections, containing both fibre types were chosen as control for 
MCT4 detection. The soleus muscle was identified according to its high content of oxidative 
muscle fibres (Figure 29 B). The staining in Figure 29 clearly shows that MCT4 is present in 
glycolytic and absent from oxidative muscle.  
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Figure 29 The presence of MCT1, MCT2 and MCT 4 in mouse cardiomyocytes  
A Cryostat section of the left ventricle of the mouse heart (p20, black 6 mouse). MCT4 signal is shown in green 
(absent); nuclei are shown in blue. B Positive control: in a cryostat section of the lower hind limb (p20, black 6 
mouse) MCT4 (green) and slow myosin (red; indicates oxidative myocytes) were detected; nuclei are shown in 
blue. C Isolated cardiomyocyte (p21, black 6), that had been cultured for 24 h prior to MCT1 detection (green); 
nuclei are shown in blue. D Western blot with MCT1 detection. 20 µg of cardiomyocyte lysates from 3 different 
animals (p20± 2, Black-6) (C) or 20 µg of lysed Xenopus oocytes (O), heterologously expressing MCT1, were 
loaded per lane, respectively. E Western blot with MCT2 detection. 20 µg of cardiomyocyte lysates from 2 different 
animals (p20± 2, Black-6) (C) or 20 µg of lysed Xenopus oocytes (O), heterologously expressing MCT2, were 
loaded per lane, respectively. 
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Figure 30 The Km for lactate influx into cardiomyocytes 
The Km was determined in HEPES-buffered solution (pH 7.4) 
A Recordings of cells expressing Laconic during bath application of different lactate concentrations (black). The 
kinetics of lactate are shown in blue. B Recordings of H+-imaging (SNARF black). The kinetics of H+ are shown 
in blue. C Dose-response-curve of lactate influx. The determined Km is 2 ± 0.6 mM. D Dose-response-curve of 
lactate induced acidification. The determined Km is 17 ± 1.3 mM.  
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Next Km for the lactate influx and the lactate induced ∆[H+]i/∆t into cardiomyocytes was 
determined. 
Since the Km of the rat MCT1 for lactate had been determined to be 3.5 mM (Bröer et al., 1998), 
the Km in mouse cardiomyocytes was expected to be similar, if the MCT1 was the dominating 
lactate transporter. In Figure 30 C and D the Km was determined by imaging the kinetic of the 
lactate influx and the lactate induced acidification during extracellular application of different 
lactate concentrations (0.5, 1, 3, 5, 10, 30, 50 mM). The Michaelis-Menten fit revealed a Km of 
17 ± 1.3 mM.  
When the Km for lactate influx into mouse cardiomyocytes was determined with lactate imaging 
on cells that artificially expressed the FRET based lactate sensor Laconic, a value of 2 ± 0.6 
mM was found (Figure 30).  
 
 
Figure 31 Km of lactate induced JA/B 
The lactate-induced acid/base flux (JA/B) was calculated from the measured pH kinetics or H+ kinetics, based on 
the buffer capacity (blue, 8.8 mM), on the fixed buffer ratio (red, 56089.34) and on the adaptive buffer capacity 
(black, buffer ratio= [H+]i-1.5572*4.43774*107).  
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When the Km was determined with the JA/B values, calculated from β, ρfixed and ρadap., a strong 
dependence of the method was observed (Figure 31). The use of β, ρfixed and ρadap. led to Km 
values of 10.86 mM, 15.05 mM and 7.59 mM, respectively. 
 
3.2.3 Sodium bicarbonate co-transporter (NBC) and sodium-proton exchanger (NHE) 
activity in mouse cardiomyocytes 
 
A standard method to investigate acid extruding mechanism in cardiomyocytes is the so called 
NH4Cl pre-pulse. In Figure 32 A the scheme of NH4Cl pre-pulse induced ∆[H+]i is shown. During 
NH4Cl application, NH4Cl equilibrates with NH3 in the extracellular space. The NH3 will enter to 
the cell by diffusion, causing an increase of the intracellular pH by NH4+ formation NH4+ will 
enter the cell more slowly than NH3 and counteract the rise of pH. It is not perfectly clear how 
NH4+ enters the cell, but Dart and Vaughan-Jones (1991) could show that the recovery from 
the rise of cytosolic pH in the sheep heart is independent of Na+ and Cl-, which excludes the 
involvement of the known acid/base transporters (NBC, AE (Anion Exchanger)). They did 
speculate that this might be caused by unspecific NH4+ influx via Na+/K+ ATPase or K+ channels. 
When the NH4Cl/ NH3 is removed from the extracellular environment, cytosolic NH4+ will convert 
to NH3 + H+. The NH3 leaves the cell whereas the H+ is trapped inside, causing a huge cytosolic 
acidification. This activates acid extruding mechanisms, so NHE and NBC. With inhibitors or 
restriction of substrates (Na+, HCO3-), the different acid extruders can be inhibited to dissect 
the composition of overlapping mechanisms. 
The presence of HCO3--independent, cariporide-sensitive acid extrusion in mouse 
cardiomyocytes was tested with the NH4Cl pre-pulse method. The experiment was performed 
in the nominal absence of CO2/HCO3- (HEPES-only-buffered solution). In Figure 32, the NH4Cl 
pre-pulse was performed once as control, showing all CO2/HCO3--independent acid extrusion 
and once in the presence of the NHE1 inhibitor cariporide (Ch’en et al., 2008; Orlowski and 
Grinstein, 2003). 30 µM cariporide inhibited acid extrusion (∆[H+]i/∆t) by 86% (Figure 33).  
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Figure 32 Acid extruding mechanisms in mouse cardiomyocytes  
A Scheme of NH4Cl pre-pulse induced cytosolic H+ load. B 30 µM of the NHE inhibitor cariporide completely 
inhibited the acid extrusion in nominal absence of CO2/HCO3-. Introduction of CO2/HCO3- in the presence of 
cariporide resulted in an increase of cellular pH. The kinetics of H+ are shown in blue. C In absence of extracellular 
Na+, CO2/HCO3--independent acid extrusion is inhibited. For statistics see Figure 33 and Table 16. 
 
A 
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Figure 33 Dissection of ∆[H+]i /∆t mediating mechanisms after acid load 
A H+ recordings from ammonium pre-pulse induced cytosolic acidification in HEPES-buffered solution (red), 
HEPES-buffered solution without Na+ (green), HEPES-buffered solution with 30 µM cariporide (grey), CO2/HCO3-
-buffered solution (black), CO2/HCO3--buffered solution containing cariporide at a concentration of 30 µM (blue) 
and CO2/HCO3--buffered solution without Na+ (orange). Sodium dependence of H+ extrusion was tested with 
sodium free solutions. B Statistics of the acid extrusion shown in A. The maximal ∆[H+]i/∆t of H+ extrusion after 
NH4Cl removal was analysed.  
 
To test for Na+ dependence of the cariporide sensitive acid extruder, the NH4Cl pre-pulse 
experiment was performed in the absence of extracellular Na+ as well. In absence of 
extracellular Na+, ∆[H+]i became even bigger than in the presence of cariporide and ∆[H+]i/∆t 
was reduced by 119%.  
To test for CO2/HCO3--dependent acid extrusion, in the condition of cariporide inhibited acid 
extrusion, CO2/HCO3- was applied (Figure 32). The cells showed an immediate increase of 
cytosolic pH. 
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The acid extruding mechanisms are dissected and compared in Figure 33. The measured 
∆[H+]i/∆t is shown in Table 16. The different effects of substrate omission and of inhibitors are 
shown in Table 17. 
Table 16 ∆[H+]i / ∆t after NH4Cl pre-pulse 
Medium nM/min Standard error 
HEPES-only -44.19 7.03 
HEPES-only (0 Na+) 8.54 5.61 
HEPES-only (30 µM 
cariporide) -6.14 5.79 
CO2/HCO3-  -68.65 5.27 
CO2/HCO3- (30 µM 
cariporide) -59.52 4.65 
CO2/HCO3- (cariporide +0 
Na+) -22.32 5.79 
 
Table 17 Dissection of ∆[H+]i / ∆t contributors after acid load 
in HEPES-only Reduction (%) 
cariporide (30 µM) vs. HEPES-only 86.11 
0 Na+ in HEPES-only vs. HEPES-only 119.33 
in CO2/HCO3- buffer 
cariporide (30 µM) vs. CO2/HCO3- 13.3 
cariporide (30 µM) and 0 Na+ vs. CO2/HCO3- 67.49 
cariporide (30 µM) and 0 Na+ vs. cariporide 62.5 
Reduction in HEPES-only buffer vs. 
CO2/HCO3- buffer 35.64 
  
The acid extrusion was also analysed as JA/B because the exponential behaviour of ρ (Figure 
18) indicates a strong impact of [H+]i on ∆[H+]i/∆t. This was compensated by the use of ρadap. 
(Figure 34).
 
The determined values for JA/B are shown in Table 18. The different effects of 
substrate omission and of inhibitors are shown in Table 19. 
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Figure 34 Dissection of JA/B mediating mechanisms after acid load 
JA/B was calculated according ρadap. for HEPES-only and CO2/HCO3--buffered conditions (Figure 18). The values 
for JA/B are shown in Table 18. 
Table 18 JA/B after NH4Cl pre-pulse 
Medium JA/B (mM/min) 
Standard 
error 
HEPES-only -0.287 0.0267 
HEPES-only (0 Na+) -0.017 0.009 
HEPES-only (30 µM 
cariporide) -0.0637 0.018 
CO2/HCO3- -3.2237 0.15 
CO2/HCO3- (30 µM 
cariporide) -2.4857 0.195 
CO2/HCO3- (cariporide 
+0 Na+) -0.75 0.164 
 
Table 19 Dissection of JA/B contributors after acid load 
in HEPES-only Reduction (%) 
cariporide (30 µM) vs. HEPES-only 78.01 
0 Na+ in HEPES-only vs. HEPES-only 94.17 
in CO2/HCO3- buffer 
cariporide (30 µM) vs. CO2/HCO3- 22.9 
cariporide (30 µM) and 0 Na+ vs. CO2/HCO3- 76.7 
cariporide (30 µM) and 0 Na+ vs. cariporide 69.8 
Reduction in HEPES-only buffer vs. 
CO2/HCO3- buffer 91.1 
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3.2.3.2 S0859-sensitive and insensitive Na+- and HCO3--dependent H+ extrusion 
To clearly dissect the NBC activity from all other mechanism, the NBC inhibitor S0859 was 
used.  
 
Figure 35 Mouse cardiomyocytes contain a S0859 sensitive and an insensitive NBC isoform 
A Recordings from 15 cells were averaged for the average trace (black). High extracellular K+ (40 mM) did not 
alter cytosolic pH or H+ extrusion. In sodium free solution, the H+ extrusion was significantly reduced, even though 
not completely abolished. The S0859 showed an inhibiting effect (S0859 sensitive; green) on H+ extrusion in 7 
out of 15 cells, whereas 8 out of 15 cells were S0859 insensitive (red). B Statistics of the experiment shown in A. 
The maximal acidification and the maximal speed of H+ extrusion after NH4Cl removal were analysed. If 
significance is not indicated, there was no significant difference observed between sensitive and insensitive cell 
types.  
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This inhibitor was described by Ch’en et al. (2008) to completely block the NBC activity at a 
concentration of 30 µM in rat, rabbit and guinea pig cardiomyocytes. In this work the acid 
extrusion (∆[H+]i/∆t) showed an average reduction of 53% when S0859 (30 µM) was applied. 
But the cells did respond in an individual degree to the inhibitor. 62 cells were analysed. In 24%, 
S0859 reduced acid extrusion (∆[H+]i/∆t) by 90% or more and in 33.9% of the cells acid 
extrusion was reduced by less than 10%. In Figure 35, a S0859 sensitive and an insensitive 
fraction are compared.  
Depolarization of cardiomyocytes with high extracellular K+ (40 mM) did not speed up the acid 
extrusion from mouse cardiomyocytes (Figure 35) as described by Yamamoto et al. (2005) for 
guinea pig, rat and rabbit cardiomyocytes. Yamamoto et al. (2005) referred this electrogenic 
acid extrusion to the NBCe1. The presence of this membrane transporter in mouse 
cardiomyocytes was tested with western blot. The NBCe1 was detected in WT mouse brain 
samples but not in WT heart or NBCe1 knock out samples (Figure 36). 
 
Figure 36 Western blot with NBCe1 detection  
Western blot for NBCe1 detection with brain and heart tissue samples from WT and NBCe1-KO animals. The 
expected size of NBCe1 is 120 kDa (Garciarena et al., 2013). Each sample was loaded as pair.  
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3.2.3.3 Na+-independent, HCO3--dependent acid extrusion 
In the presence of CO2/HCO3-, acid extrusion persisted in Na+ free solution (as shown in the 
red and green trace in Figure 35 and Figure 37) but not in its nominal absence (HEPES-only-
buffered solution).  
 
In a group of cardiomyocytes (6 out of 30, 20%), the acid extrusion was reduced by less than 
10% in the absence of extracellular Na+ (Figure 37 orange trace). 
 
 
Figure 37 Na+-independent, 
HCO3--dependent acid 
extrusion 
The green and red traces are the 
same as shown in Figure 35. 
The orange trace was recorded 
in the same experiment and 
shows a third type of 
cardiomyocytes, which extrude 
H+-independent from 
extracellular sodium. 
The pH recordings were noise 
filtered with the program clampfit 
at a threshold of 0.012 Hz. For 
this experiment, a black 6 mouse 
was used at an age of p19.  
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3.2.3.4 Threshold of CO2/HCO3--independent acid extrusion 
In HEPES-only-buffered solution, the acid extrusion after NH4Cl induced acidification did not 
reach back the baseline pH but was calculated with an exponential fit to stop at pH 6.82 (Figure 
38). In contrast, acid extrusion in CO2/HCO3--buffered solution was calculated to persist until 
pH 7 was reached. 
 
 
3.2.3.5 Functional interaction of NBC and CA 
 
The cariporide-insensitive, CO2/HCO3--dependent acid extrusion (after NH4Cl pre-pulse 
induced cytosolic H+ load) was measured in the presence and absence of EZA (30 µM). JA/B 
was calculated with ρadap. (Figure 39). The cariporide insensitive, CO2/HCO3--dependent JA/B 
was determined to be 2.59 ± 0.27 mM/min. In the presence of EZA (30 µM), JA/B reduced by 
78.4% to 0.56 ± 0.16 mM/min. In Table 20 the JA/B as calculated according to ρadap. and β are 
compared. 
Figure 38 Threshold of CO2/HCO3--
independent acid extrusion 
In HEPES buffered solution, the acid 
extrusion after NH4Cl induced acidification 
stopped before the cytosolic pH reached the 
baseline. The new baseline after acid 
extrusion in HEPES-only-buffered solution 
(black) was calculated with the exponential 
fit:  Y= 309.98*exp(-X/45.62)+150.86. The 
new baseline after acid extrusion in 
CO2/HCO3--buffered solution (grey) was 
calculated with the exponential fit:  Y= 
3.56614*106*exp(-X/24.31)+99.9. 
The new baselines in HEPES-only and 
CO2/HCO3--buffered solution were 
determined at 151 nM H+ or pH 6.82 and 99.9 
nM H+ or pH 7, respectively. 
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Table 20 Effect of EZA on HCO3--dependent acid extrusion 
Calculation of JA/B 
JA/B (mM/min) cariporide 
insensitive 
JA/B (mM/min) cariporide 
insensitive, EZA sensitive 
Reduction of JA/B by EZA  
(30 µM, %) 
with ρadap. 2.59 ± 0.27 0.56 ± 0.16 -78.4 
with β 3.4 ± 0.25 1.6 ± 0.11 -53.3 
 
 
 
Figure 39 Effect of EZA on HCO3--
dependent acid extrusion 
The acid extrusion after NH4Cl induced H+
load in absence and presence of EZA (30 
µM). The NHE was inhibited with cariporide 
(30 µM). The measured ∆[H+]i/∆t was 
converted to JA/B with ρadap.. 
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3.3 Lactate flux and physiological implementation 
3.3.1 Lactate uptake 
 
The lactate-induced acidification was measured by pH imaging with the cytosolic pH sensor 
SNARF. Lactate transport was investigated with a lactate concentration of 3 mM because this 
was the approximate Km of myocardial lactate uptake and within the expected range of 
physiological blood lactate levels (0.64 mM at rest and 1.4 mM after 5 min physical activity; 
Gertz et al., 1988; up to 10 mM according to Scheuermann et al., 2000). H+ or pH imaging can 
be used to determine the lactate flux. This is possible since lactate is transported via MCTs 
along with H+.   
Extracellular application of lactate (3 mM) caused ∆[H+]i/∆t of 20.77 ± 1.3 nM/min, 16.86 ± 1.2 
nM/min and 25 ± 2.5 nM/min in HEPES-only-, CO2/HCO3-- and CO2/HCO3--buffered conditions 
in the presence of EZA (30 µM), respectively (Figure 40). Thus, ∆[H+]i/∆t was reduced in 
CO2/HCO3--buffered conditions by 18.8%. Inhibition of CA with EZA (30 µM) increased ∆[H+]i/∆t 
by 48.7%. The maximal ∆[H+]i was 17.4 ± 1.3 nM, 14.3 ± 1.8 nM and 22 ± 2.9 nM in HEPES-
only, CO2/HCO3- and CO2/HCO3--buffered conditions in the presence of EZA (30 µM), 
respectively. The basal [H+]i was determined to be 70.2 ± 2.6 nM, 72.5 ± 6 nM and 66.4 ± 6.4 
nM in HEPES-only, CO2/HCO3- and CO2/HCO3--buffered conditions in the presence of EZA (30 
µM), respectively. 
The lactate (3 mM) induced JA/B was determined according to β, ρfixed and ρadap.. The JA/B values 
are shown in Figure 41and Table 21. The effects of the buffering conditions on JA/B are shown 
in Table 22.  
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Figure 40 Measurement of lactate-induced acidification in different buffers  
Experiments were performed in mouse cardiomyocytes, loaded with the H+-sensitive dye SNARF-5F in a 
calibrated system. A Recordings of H+-imaging. The lactate induced changes in cytosolic H+ concentration 
are shown in the upper part as black traces. In the lower part, the kinetics of [H+]i are shown in blue. B 
Statistics of the lactate induced, cytosolic ∆[H+]i/∆t. C Amplitude of lactate induced acidification with 3 mM 
lactate D Basal cytosolic H+ concentration in different buffers.  
A B 
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Table 21 Lactate (3 mM) induced JA/B according to β, ρfixed and ρadap 
Buffering conditions ∆pH/∆t*β (mM/min) ∆[H
+]i/∆t*ρfixed*10-
6(mM/min) 
∆[H+]i/∆t*ρadap.*10-6 
(mM/min) 
HEPES-only 0.77 ± 0.057 1.17 ± 0.07 0.87 ± 0.05 
CO2/HCO3- 2.52 ± 0.062 2.98 ± 0.2 3.29 ± 0.25 
CO2/HCO3- + EZA (30 µM) 1.36 ± 0.046 2.41 ± 0.24 1.88 ± 0.16 
 
Table 22 Effect of buffering condition on JA/B according to β, ρfixed and ρadap 
Buffering conditions β ∆JA/B (%) ρfixed ∆JA/B (%) ρadap. ∆JA/B (%) 
HEPES-only vs. CO2/HCO3- +228.4 +155.7 +276.9 
CO2/HCO3- vs. CO2/HCO3- + 
EZA (30 µM) -46.2 -19.2 -42.8 
HEPES-only vs. CO2/HCO3- + 
EZA (30 µM) +76.7 +106.6 +115.7 
Figure 41 Lactate (3 mM)  induced JA/B according to β, ρfixed and ρadap. 
A Calculated values for lactate influx according to the buffer capacity B Calculated values for the acid influx 
according to ρfixed C Calculated values for the acid influx according to ρadap.. The values are shown in Table 
21. 
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The real lactate flux was determined by lactate imaging with the FRET-sensor Laconic. During 
this work, it was not possible to calibrate the system for lactate imaging, thus the measured 
∆[lac-]i/∆t is shown in arbitrary units. The measured values are shown in Figure 42 and Table 
23. The effect of the buffering system on the lactate flux is shown in Table 24. 
 
Table 23 Lactate influx during extracellular application (3 mM) 
Buffering conditions ∆[lac-]i/∆t (a.u./min) 
HEPES-only 0.0566 ± 0.0047 
CO2/HCO3- 0.0782 ± 0.0065 
CO2/HCO3- + EZA (30 µM) 0.057 ± 0.0046 
 
 
 
Figure 42 Lactate uptake measured with Laconic 
A Lactate was applied at a concentration of 3 mM in HEPES-only, CO2-buffered and CO2-buffered solution 
containing 30 µM of the CA inhibitor EZA. Experiments were performed with cardiomyocytes containing 
the lactate sensor Laconic. Changes in lactate concentration are shown in black, whereas ∆[lac-]i/∆t is 
shown in blue. B Statistics of the lactate influx. Significance was tested with a paired student‘s t test.  
A B 
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Table 24 Effect of buffering system on lactate influx during extracellular application (3 mM) 
Buffering conditions 
∆[lac-]i/∆t (a.u./min) 
(%) 
HEPES-only vs. CO2/HCO3- +38 
CO2/HCO3- vs. CO2/HCO3- + 
EZA (30 µM) -27 
HEPES-only vs. CO2/HCO3- + 
EZA (30 µM) +0.68 
 
3.3.2 Non-catalytic interaction of MCT and extracellular CA 
 
For the extracellular CAs CAIV and CAIX a non-catalytic interaction with the MCT1 was 
observed (Klier et al., 2013 and Michael Klier, unpublished data). CAIV, CAIX and CAXIV were 
reported in mouse cardiomyocytes by Scheibe et al. (2006). Since the CAIV was found to be 
absent from mouse cardiomyocytes in this work, a potential non-catalytic interaction of CAIV 
and MCT was not further investigated. The potential non-catalytic interaction of MCT1 and CAIX 
was investigated by pH imaging with SNARF in HEPES-only-buffered solution. 
 
 
Lactate induced ∆[H+]i/∆t in HEPES-only-buffered conditions was not differing between WT and 
CAIX-/- cardiomyocytes (Figure 43). 
Figure 43 Non-catalytic interaction of MCT1 and CAIX 
Lactate (10 mM) induced ∆[H+]i/∆t in HEPES-only-
buffered conditions in WT and CAIX-/- cardiomyocytes. 
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The potential non-catalytic interaction of MCT1 and CAXIV was investigated by H+ imaging with 
SNARF in HEPES-only-buffered solution. Lactate induced ∆[H+]i/∆t in HEPES-only-buffered 
conditions was not differing between WT and CAXIV-/- cardiomyocytes (Figure 44). 
 
3.3.3 Effect of cellular respiration on lactate influx 
 
If lactate is consumed for ATP generation, this must be linked to CO2 formation. In this work, 
extracellular CA activity (Figure 25) and its impact on NBC activity are shown (Figure 39). Thus, 
it was tested if omission of O2 has an effect on ∆[H+]i/∆t (Figure 45). If extracellular lactate (3 
mM) was applied in HEPES-only-buffered solution, gassed with 100% O2, the measured 
∆[H+]i/∆t was 11.06 ± 0.36 nM/min. In 100% N2 gassed solution ∆[H+]i/∆t increased by 12.6% 
to 12.46 ± 0.34 nM/min. When EZA (30 µM) was applied in 100% O2 gassed solution, ∆[H+]i/∆t 
increased by 8% from 11.9 ± 0.3 nM/min to 12.9 ± 0.35 nM/min. 
 
Figure 44 Non-catalytic interaction of MCT1 and CAXIV 
Lactate (3 mM) induced ∆[H+]i/∆t in HEPES-only-buffered 
conditions in WT and CAXIV-/- cardiomyocytes. 
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 3.3.4 Functional interaction of MCT with NHE and/or NBC 
 
3.3.4.1 Impact of NHE on lactate uptake  
 
The effect of NHE on the lactate flux was tested with lactate imaging by the use of the NHE 
inhibitor cariporide (Figure 46). When lactate (3 mM) was applied in the presence of the NHE 
inhibitor cariporide (30 µM), ∆[lac-]i/∆t (0.0183 ± 0.0017 ∆a.u./min) was not differing from ∆[lac-
]i/∆t (0.0186 ± 0.0016 ∆a.u./min) measured in the absence of cariporide. 
Figure 45 Effect of cellular respiration on lactate uptake  
In HEPES-only-buffered solution, either gassed with 100% O2 or 100% N2, lactate induced H+ concentration 
changes were measured. A Recordings of H+-imaging. The lactate induced changes in cytosolic H+-concentration 
are shown in the upper part as black traces. In the lower part, ∆[H+]i/∆t is shown in blue. B Statistics of the 
lactate induced ∆[H+]i/∆t. 
A B 
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Figure 46 Effect of NHE on lactate influx 
A Lactate imaging of cardiomyocytes expressing the lactate sensor Laconic. 3 mM lactate were applied in 
absence and presence of 30 µM cariporide. ∆[lac-]i/∆t is shown in blue. B Statistics. For this experiment, 
1 black-6 mouse was used at an age of p20. The measurements were performed at day 4 in vitro.  
 
A B 
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3.3.4.2 S0859 inhibits lactate-induced acidification 
 
The impact of the NBC in the lactate transport was tested by utilization of the NBC inhibitor 
S0859.  
 
When lactate (3 mM) was applied to cardiomyocytes in the presence of S0859 (30 µM), the 
lactate induced ∆[H+]i/∆t decreased by 26% from 5.1 ± 0.35 nM/min to 3.8 ± 0.25 nM/min 
(Figure 47).  
3.3.5 Lactate metabolism 
 
Experiments to test cardiomyocytes’ lactate metabolism were performed with cells artificially 
expressing the lactate sensor Laconic. Lactate was applied at a concentration of 3 mM in the 
presence of glucose (1 mM). When the lactate signal had been in a plateau for 10 min, the MCT 
inhibitor ARC155858 was added at a concentration of 300 nM (Figure 48). The intracellular 
lactate concentration dropped with a ∆[lac-]i/∆t of 0.0027 ± 0.00036 ∆a.u./min.  
Figure 47 S0859 inhibits lactate induced ∆[H+]i/∆t 
A 3 mM lactate were bath applied in the absence and presence of the NBC inhibitor S0859. Recordings 
of H+-imaging (black). ∆[H+]i/∆t is shown in blue. B Statistics of ∆[H+]i/∆t.  
A B 
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When the respiratory chain was inhibited with NaN3 (5 mM) in the presence of ARC155858 
(300 nM), the intracellular lactate concentration rose with a ∆[lac-]i/∆t of 0.035 ± 0.0054 
Figure 48 Lactate metabolism in mouse cardiomyocytes  
A Averaged recording of 5 Laconic (lactate sensor) expressing cardiomyocytes. In presence of lactate (3 
mM), the MCT1/MCT2 inhibitor AR C155858 was bath applied to prohibit lactate exchange. B Statistics of 
drop and rise of [lac-]i in presence of AR C155858 after cellular lactate load and inhibition of the respiratory 
chain with NaN3, respectively. C Averaged recording of 13 cardiomyocytes expressing the lactate sensor 
Laconic. D Statistics of the rise of [lac-]i after application of AR C155858 and after inhibition of the 
respiratory chain with NaN3, respectively. 
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∆a.u./min. When ARC155858 was applied in the absence of extracellular lactate, the 
intracellular lactate concentration rose with a ∆[lac-]i/∆t of 0.002 ± 0.00036 ∆a.u./min.  
 
The inhibition of MCT with ARC155858 after cellular lactate load caused a decrease of 
intracellular lactate concentration. If this was due to lactate consumption, cellular uptake of 
lactate must have been converted to pyruvate. This was tested with pyruvate imaging (Figure 
49). When lactate was applied to cardiomyocytes expressing the pyruvate sensor Pyronic, an 
increase in [lac-]i was observed.  
 
 
  
Figure 49 Cytosolic conversion of lactate to 
pyruvate 
Recording of a cardiomyocyte, expressing 
the pyruvate sensor. 1 mM pruvate and 3 
mM lactate were bath applied. N=10 
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4. DISCUSSION 
4.1 Discussion - Proteins (CAs, MCTs, NBC and NHE in mouse cardiomyocytes) 
4.1.1 Discussion - Proteins - Carbonic anhydrases in mouse cardiomyocytes 
 
4.1.1.1 Intracellular carbonic anhydrase 
 
Intracellular CA activity in ventricular rat cardiomyocytes was reported by Schroeder et al. 
(2013) and Villafuerte et al. (2014). In western blot experiments, Alvarez et al. (2013 and 2007) 
detected the cytosolic CAII in human, rat and mouse heart, Schroeder et al. (2013) detected 
the CAII in the rat heart, too. In contrast, Geers et al. (1992), Vuillemin and Pexieder (1997) 
and Vandenberg et al. (1996) report evidence for the absence of CAII from rabbit, post natal 
mouse and ferret cardiomyocytes, respectively. Roughton (1935) reports the complete absence 
of CA activity from the heart, but does not specify which species had been investigated. 
Attempts to detect the CAII in mouse cardiomyocytes with immunohistochemistry resulted in 
signals in WT and CAII-/- animals. There was a minimal chance that the signal in the CAII-/- 
animals might have been caused by CAII fragments. But this can be excluded because CAII 
signals were absent from CAII-/- samples in Western blot experiments. If CAII fragments would 
have caused the signals in CAII-/- cardiomyocytes, a protein, smaller than CAII should have 
been detected in the Western blot. Thus, it must be concluded that CAII detection with 
immunohistochemistry failed due to unspecific antibody binding. In western blot experiments, 
the CAII was detected in the WT heart but this is most likely due to erythrocytes that could not 
be completely removed from the sample (Geers et al., 1992) and which contain CAII (Sly and 
Hu, 1995). Intracellular CA activity was not observed in mouse cardiomyocytes in this work. 
This conclusion is based on the finding that the CA inhibitor EZA (30 µM) did not have a 
significant effect on the intracellular CO2-induced acidification. When the same experiment was 
performed with MCF-7 cells (Somayeh Jamali, personal communication) or with 10 µM EZA in 
astrocytes from brain slices (Stridh et al., 2012), CA inhibition resulted in a significant reduction 
in the speed of CO2-induced acidification. Astrocytes and MCF-7 cells are reported to contain 
CAII (Stridh et al., 2012 and Somayeh Jamali, personal communication, respectively). 
Therefore, in cardiomyocytes a similar effect should have been observed if cytosolic, EZA 
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sensitive CA would have been present. This led to the last option for intracellular CA activity in 
mouse cardiomyocytes: the CAIII. This isoform has been reported to have a comparatively high 
Ki for EZA (60 µM; Geers et al., 1992) and therefore might not have been inhibited at a 
concentration of 30 µM. In addition, western blot experiments revealed that the used antibody 
for CAII detection also detects CAIII. But in immunohistochemistry experiments, no signals for 
CAIII were observed in mouse heart sections. Signals for CAIII in the soleus muscle, as 
reported for the rat soleus muscle (Shiels et al. 1982), confirmed that antibody and staining 
procedure worked, so that it can be concluded that CAIII is absent from the mouse heart, as 
previously reported by Tweedie and Edwards (1989).   
However, the live cell imaging experiments by Schroeder et al. (2013) and Villafuerte et al. 
(2014) provide strong evidence for cytosolic CA activity in rat cardiomyocytes. The discrepancy 
between this work and the reports by Schroeder et al. (2013) and Villafuerte et al. (2014) about 
intracellular CA activity might be due to the fact that they have been working on rat, whereas 
experiments in this work have been performed with mouse cardiomyocytes.  
4.1.1.2 Extracellular carbonic anhydrase 
 
Different membrane bound, extracellular CAs have been reported in mouse cardiomyocytes. 
Scheibe et al. (2006) reported the isoforms CAIV, CAIX and CAXIV on the protein level in 
mouse cardiomyocytes. Alvarez et al. (2013) detected the CAIV and CAXIV in the human and 
mouse heart. Sender et al. (1998) reported the CAIV in the human and rat heart. Furthermore, 
Geers et al. (1992) could detect CA activity in the membrane fraction of lysed rabbit hearts and 
Vandenberg et al. (1996) could observe CA activity at the sarcolemma of cardiomyocytes from 
the ferret heart. In this work, the presence of extracellular, EZA-sensitive CA activity on mouse 
cardiomyocytes was confirmed by H+ imaging. But it was not clarified which isoform is 
responsible for the observed activity. 
Scheibe et al. (2006) compared wild type and CAIV-KO animals in western blot and 
immunocytochemistry experiments. In their study they detect the CAIV in heart samples of wild 
type animals but not in CAIV-KO animals, indicating that the antibody used is specific. In 
immunocytochemistry experiments they found a CAIV signal in mouse cardiomyocytes that was 
abolished by antibody pre-absorption and absent from CAIV-KO animals. Their approach 
includes all possible controls and therefore it must be considered valid. In contrast, in this work 
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the CAIV was detected in the mouse heart with western blot at the correct size of approximately 
30 kDa (Klier et al. 2013). With immunohistochemistry experiments on sections of the WT and 
in CAIV KO mouse heart, the CAIV was detected in the WT samples but was absent from the 
CAIV KO. This indicates that antibody and staining procedure lead to specific signals. However, 
immunocytochemistry on dissociated heart samples revealed that the CAIV signals are not 
derived from cardiomyocytes, but from round cells that were not further identified during this 
work. Since the murine heart is reported to consist of about 30% fibroblasts (Banerjee et al., 
2007), those might be likely candidates.  
The CAIX was found to be hypoxia and cancer associated and provides therefore hope as new 
target for cancer therapies (Ivanov et al., 1998; Pastorekova et al., 2004; Potter and Harris, 
2008; Robertson et al., 2004). As the CAIX grows more and more interesting as potential cancer 
target, more and more research is focusing on this isoform. Recent research questions an 
exclusive relation to cancer. Orlowski et al. (2012) reports the CAIX in rat cardiomyocytes, 
whereas Scheibe et al. (2006) found the CAIX in mouse cardiomyocytes. Hilvo et al. (2004) 
could not find CAIX mRNA in the mouse heart, but in several other tissues, including lungs, 
kidney, liver, stomach and intestine (see also: Gut et al., 2002 and Pan et al., 2012). If CAIX’s 
presence in the human heart would be confirmed, its use as cancer therapy target might be 
questioned. Anyway, CAIX’s presence in the heart would be surprising because the CAIX is 
reported to be linked to hypoxia (Wykoff et al., 2000), which is not expected to occur in healthy 
myocardial tissue. Therefore, CAIX’s presence in the mouse heart would need to be hypoxia-
independent and mediated by some other pathways than via hypoxia-inducible factor 1 (HIF-
1). However, CAIX’s presence in mouse cardiomyocytes was neither confirmed nor excluded 
in this work. With immunohistochemistry, CAIX signals were detected in heart sections as well 
as in stomach sections. In CAIX-/- animals, CAIX signals were present in stomach sections, too. 
This can be either explained by unspecific antibody binding or by CAIX fragments in the KO 
animal. In the CAIX-/- animals the gene Car9 is not removed but the enzymatic function is 
destroyed by a nonsense insertion into exon 1 (Gut et al., 2002). Therefore, it is thinkable that 
the CAIX epitopes are still present in CAIX-/- animals. But Gut et al. (2002) did not report any 
CAIX signals in western blot or immunohistochemistry experiments with CAIX-/- stomach 
samples. In addition, in the work by Scheibe et al. (2006) no signals were observed in CAIX-/- 
cardiomyocytes. Therefore, unspecific antibody binding in this work appears likely, even though 
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the observed staining pattern matches the reported CAIX distribution in the stomach, where the 
strongest signals were observed in the epithelium (Gut et al., 2002). 
However, it remains unclear which CA isoform is responsible for the observed extracellular 
CA activity. 
 
4.1.2 MCTs in mouse cardiomyocytes 
 
The lactate transport across the sarcolemma in cardiomyocytes is mediated by mono-
carboxylate transporters (MCTs). Bonen (2001) found weak evidence of MCT4’s presence in 
the human heart and MCT4 detection in rat heart remained negative. The MCT2 mRNA was 
not detected in the mouse heart (Jackson et al., 1997) whereas the results of Koehler-Stec et 
al. (1998) provided a very faint signal for MCT2 mRNA in the mouse heart (Koehler-Stec et al., 
1998; Fig. 5). Pierre and Pellerin (2005) report that MCT2 was not detected in mouse heart 
samples with western blot, even though their results contain a faint signal for MCT2 in heart 
samples (Pierre and Pellerin, 2005; Fig. 1). However, there is only weak evidence for MCT2’s 
presence in the mouse heart. The only isoform, whose presence in the heart has been 
confirmed by several authors is the MCT1 (Bonen, 2001; Koehler-Stec et al., 1998; Lin et al., 
1998; Martinov et al., 2009; Pierre and Pellerin, 2005). 
The Km value for lactate uptake, determined in this work by lactate imaging is 2 mM. This value 
matches the values reported for MCT1 (3.5 mM; Bröer et al., 1998), when expressed in 
Xenopus oocytes. The Km for the lactate-induced acidification, determined by H+ imaging from 
∆[H+]i /∆t is 17 mM and therefore suggests the presence of an additional lactate transporter with 
a higher Km. The best candidate would be the MCT4 (Km: 28 mM Fox et al., 2000), which was 
shown to be absent from mouse cardiomyocytes in this work. Hence, the cause for this high Km 
must have other reasons. 
When the buffer ratio was plotted against the basal [H+]i of individual cardiomyocytes, an 
exponential relation was observed. This means that the buffer ratio changes when [H+]i 
changes. Therefore, a doubled JA/B would not lead to a doubled ∆[H+]i /∆t, because the buffer 
ratio adapts during JA/B. When lactate was applied to the cardiomyocytes at a concentration of 
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1 mM, the measured maximal ∆[H+]i /∆t was 4.96 nM/min. If lactate was applied at a 
concentration of 10 mM, ∆[H+]i /∆t was 36.31 nM/min. This means that the lactate-induced 
cytosolic H+ load is 7.3 times faster when the applied concentration is increased from 1 mM to 
10 mM. The calculated JA/B by the use of the adaptive buffer ratio was determined to be 0.48 
mM/min when lactate was applied at a concentration of 1 mM and increased to 2.79 mM/min 
when the concentration of applied lactate was increased to 10 mM. This is a factor of 5.8. So, 
the measured ∆[H+]i /∆t seams to provide a distorted picture of JA/B. This is caused by the fact 
that the buffer ratio reduces with increasing [H+]i. Thus, the same amount of H+ entering the cell 
from a higher baseline but within the same time will cause a higher ∆[H+]i/∆t. Consequently, the 
bigger JA/B, the stronger ∆[H+]i will be enhanced by the falling buffer ratio. This is probably the 
reason for the high Km as determined from ∆[H+]i /∆t. When the Km was determined with JA/B as 
calculated according to the adaptive buffer ratio, it was determined to be 7.6 mM. This is still a 
little bit higher than the 3.5 mM as reported by Bröer et al. (1998) or the 2 mM that were 
determined by lactate imaging, but it is in the same range. The reason for the slight mismatch 
of the Km of 7.6 mM might be due to the small number of cells (n=49) used for the determination 
of the buffer ratio, which might have caused the weak R2 of the fit for the adaptive buffer ratio 
(R2 = 0.6). Since the lactate imaging data show the real lactate flux, the Km for lactate uptake 
into mouse cardiomyocytes, as determined by lactate imaging is more reliable. This view is 
supported by the finding that the determined Km (2 mM) suits best the MCT1, which is the only 
MCT that was identified in mouse cardiomyocytes among MCT1, MCT2 and MCT4 in this work. 
 
4.1.3 NHE and NBC activity in mouse cardiomyocytes 
 
The acid extruders NHE1 (Aiello et al., 1998; Ch’en et al., 2008; Choi et al., 2000; Garciarena 
et al., 2013; Khandoudi et al., 2001; Yamamoto et al., 2005) and NBCe1 (Ch’en et al., 2008; 
Yamamoto et al., 2005) are reported to be present in cardiomyocytes. In this work, the presence 
of NHE and NBC activity in ventricular mouse cardiomyocytes was observed. 
In experiments in which mouse cardiomyocytes were acidified with NH4Cl-prepulse in HEPES-
only-buffered medium, in presence of the NHE inhibitor cariporide (30 µM; Ch’en et al., 2008; 
Orlowski and Grinstein, 2003), acid extrusion in ∆[H+]i /∆t was reduced by 86% and JA/B was 
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reduced by 78%. This points to NHE activity in mouse cardiomyocytes, unless cariporide has 
some unknown, unspecific side effects.  
When CO2/HCO3- was introduced to NH4Cl-prepulse acidified cells, whose acid extrusion had 
been inhibited by cariporide, acid extrusion accelerated. This points to a HCO3--dependent acid 
extruding mechanism. In sodium free, CO2/HCO3--buffered medium, acid extrusion in ∆[H+]i /∆t 
was reduced by 63%, JA/B was reduced by 76,7%. This indicates a partial sodium dependence 
of the HCO3--dependent acid extruding mechanism. Therefore, the presence of a NBC isoform 
is likely. Ch’en et al. (2008) and Yamamoto et al. (2005) reported the electrogenic NBCe1 in rat 
cardiomyocytes. In this work, depolarisation of ventricular mouse cardiomyocytes with high 
extracellular potassium concentrations (40 mM) did not alter acid extrusion. In addition, western 
blot experiments confirmed the absence of NBCe1 from the mouse heart. Therefore, mouse 
cardiomyocytes might contain an electroneutral NBC.  
Choi et al. (2000) detected the NBCn1 on the RNA level in the rat heart. Ch’en et al. (2008) 
reported that acid extrusion from rat cardiomyocytes in CO2/HCO3--buffered medium was 
completely abolished when the NHE and NBC activity were inhibited with cariporide and the 
NBC inhibitor S0859. Therefore it can be concluded that S0859 inhibits the NBCe1 and the 
NBCn1. In this work, application of S0859 (30 µM) in the presence of cariporide (30 µM) partially 
inhibited acid extrusion. In 24% of the measured cardiomyocytes, S0859 caused a reduction in 
acid extrusion (∆[H+]i /∆t) of 90% or more. 22.6% or the cardiomyocytes show inhibition of 50% 
or more. 33.9 % of the cells showed less than 10% inhibition and are therefore considered as 
S0859-insensitive. Hence, an additional, S0859-insensitive, HCO3--dependent acid extruding 
mechanism must be active in ventricular mouse cardiomyocytes. This mechanism is most likely 
coupled to sodium because acid extrusion in cells insensitive to S0859 was reduced when 
extracellular sodium was absent. In addition, in 20% of the cells, acid extrusion in absence of 
extracellular sodium was reduced by less than 10%. In total, JA/B was reduced by 94% in 
HEPES-only-buffered conditions, whereas in CO2/HCO3- buffer, JA/B was just reduced by 76.7% 
if extracellular sodium was absent. This may indicate a third acid extruding mechanism, which 
is independent of sodium but depends on CO2/HCO3- buffer. The S0859-insensitive and Na+-
independent mechanism are not described in the literature so far and may therefore provide an 
option for future research. 
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The absence of electrogenic NBC activity from cardiomyocytes appears logical in view of their 
excitability. Cytosolic acidification would activate the electrogenic NBC, which would 
hyperpolarize the cell. This would reduce excitability, which would be in contrast to the findings 
by Garciarena et al. (2013), who reported that cardiomyocytes compensate reduced 
contractility during acid load by elevated cytosolic Ca2+ levels. Therefore cardiomyocytes’ 
strategy while facing H+ load seems to be the maintenance of contractility rather than its 
reduction. In addition, an electrogenic NBC would get active when the cell contracts. Especially 
in cardiomyocytes, which possess a comparatively long phase of depolarisation in comparison 
to neurons (Schmidt et al., 2005), an electrogenic NBC would inhibit the sodium/calcium-
exchanger, as reported by Garciarena et al. (2013) via cytosolic Na+ load. But these 
speculations are contradictory to the detection of NBCe1 activity in the rat, rabbit and guinea-
pig cardiomyocytes (Yamamoto et al., 2005). Obviously, in those species the potential 
disadvantages of electrogenic NBC activity do not affect heart activity. Why, and if electrogenic 
NBC activity might even be beneficial in those species cannot be answered here. 
No matter which NBC or NBC-like isoform is present in mouse cardiomyocytes, its activity 
strongly depends on the activity of extracellular CA. When the maximal acid extruding JA/B after 
NH4Cl induced acid load was calculated based on the adaptive buffer ratio, a reduction of 78.4% 
was observed when CA was inhibited with EZA. Since no intracellular CA activity had been 
observed during this work, the EZA effect must be caused by inhibition of extracellular CA. Thus 
it can be concluded that in ventricular mouse cardiomyocytes the activity of extracellular CA is 
of crucial importance for the NBC function. 
4.1.3.3 NHE vs. NBC activity in mouse cardiomyocytes 
 
In CO2/HCO3- buffer, the Na+-dependent but cariporide insensitive acid extruding mechanism 
contributes 53.8% of mouse cardiomyocytes total acid extruding JA/B. This fraction is most likely 
related to electroneutral NBC activity and is composed of a S0859 sensitive and a S0859 
insensitive isoform. 22.9% of acid extrusion is cariporide sensitive and is therefore considered 
to be contributed by NHE. 23.2% of acid extruding JA/B are neither Na+ nor cariporide-sensitive. 
Therefore, an acid extruding mechanism in addition to NHE and NBC must be present in 
ventricular mouse cardiomyocytes.  
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4.2 Buffer capacity vs. fixed and adaptive buffer ratio 
 
The classic measure for the cellular H+ buffering ability is the buffer capacity (Vaughan-Jones 
et al., 2002; Leem et al., 1999; Zamboni et al. 2003). The intrinsic buffer capacity in guinea-pig 
cardiomyocytes was reported to increase when the pH drops and was determined to be 
approximately 25 mM at pH 7.2 (Leem et al., 1999). This is in line with the intrinsic buffer 
capacity as determined by Zamboni et al. (2003) for rat, rabbit and guinea-pig cardiomyocytes. 
The CO2/HCO3--dependent buffer capacity was reported to increase with the cytosolic pH and 
was determined to be approximately 25 mM at pH 7.2 (Leem et al., 1999). The total buffer 
capacity βtot as the sum of βi and βCO2 was found to increase with the cytosolic pH and was 
determined to be 50 mM at pH 7.2. 
In this work, the buffer capacity of ventricular mouse cardiomyocytes was determined to be 8.8 
mM at pH 7.18 in HEPES-only-buffered and 30.24 mM at pH 7.22 in CO2/HCO3--buffered 
conditions. Here, the buffer capacity as determined in HEPES-only-buffered conditions might 
be considered as βi. But the cellular respiration might have produced enough CO2 to provide 
significant CO2/HCO3- buffering. This was not tested during this work but the experiments for 
lactate uptake in N2- and O2-gassed condition provide evidence for a contribution of 
endogenous CO2 formation to the buffering. To be on the save side, the common terms βi and 
βCO2 are not used in this work. However, the values for the buffer capacity as determined in this 
work are a bit smaller than those reported by Leem et al. (1999) for guinea-pig cardiomyocytes 
but they are in the same range. When the CA was inhibited with EZA, the buffer capacity was 
determined to be 13.1 mM. This is a reduction of the buffer capacity by 56.7%, which means 
that more than half of the buffer capacity in CO2/HCO3--buffered conditions is dependent on the 
activity of extracellular CA. This can be explained by extracellular CA’s effect on the NBC 
activity. Theparambil et al. (2014) could show that in cortical astrocytes, the NBCe1 is defining 
the CO2/HCO3--dependent buffer capacity. Therefore, also other NBC isoforms might contribute 
to the cellular buffer capacity. 
Another way to describe the cellular H+ buffering properties is the so called buffer ratio ρ 
(Michael Dietrich, unpublished). The difference between β and ρ is:  β= ∆[B-]i/∆pHi whereas ρ= 
∆[B-]i/∆[H+]i. It appears to be more intuitional to consider the ∆[H+]i than ∆pHi because of the 
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logarithmic nature of pH. This means that if the pH changes from 7.0 to 6.0 or 8.0, ∆pHi is 1. 
But if the same pH change is considered as [H+]i, pH 7.0 is a [H+]i of 100 nM, pH 6.0 is a [H+]i 
of 1000 nM and pH 8.0 is a [H+]i of 10 nM. Hence, ∆[H+]i from pH 7.0 to 6.0 is 900 nM whereas 
∆[H+]i from pH 7.0 to 8.0 is 90 nM, so 10 times less. Thus, if the intracellular concentration of 
free H+ is measured in ∆pHi, acidifications are smaller and alkalinisations are bigger than in 
∆[H+]i. 
However, the use of β and ρfixed in this work is the calculation of JA/B. For this, the measured 
∆pHi/∆t was multiplied with β and the measured ∆[H+]i/∆t was multiplied with ρfixed. This was 
done for the lactate-induced acidification in HEPES-only-, CO2/HCO3-- and CO2/HCO3--buffered 
conditions in the presence of EZA (30 µM). The JA/B derived from ∆pHi/∆t and β shows a similar 
behaviour as the lactate flux measured with lactate imaging. The JA/B derived from ∆[H+]i/∆t and 
ρfixed shows a similar behaviour as the lactate flux in HEPES and CO2/HCO3- conditions, but the 
effect caused by EZA is less prominent than in the lactate flux. In lactate imaging experiments, 
the reduction of lactate influx by inhibition of CA was 27%, the reduction of JA/B derived from 
∆pHi/∆t and β was 48.9% and the reduction of JA/B derived from ∆[H+]i/∆t and ρfixed was 19.2%.  
The determined β and ρ were plotted against the basal pH and [H+]i, respectively. β showed a 
broad scattering and no clear correlation with the basal pH. In contrast, for ρ an exponential 
correlation with the basal was [H+]i obvious, even though the R2 for CO2/HCO3- conditions was 
week. This might have been due to a small n number. However, the buffer ratio increases when 
[H+]i drops. Hence, a fixed, averaged value for ρ must cause an error in the calculated JA/B as 
individual cells possess individual basal [H+]i and because ρ will change during JA/B. The 
equation of the fit describing the correlation was used to convert the SNARF recordings, that 
had been calibrated to [H+]i, to ρ/t. So, a trace showing the buffer ratio at each moment of the 
measurement was produced. This buffer ratio will take into account individual variations of the 
basal [H+]i and corrects the changes of ρ during JA/B. This buffer ratio was named adaptive 
buffer ratio ρadap.. 
When the JA/B was determined with ρadap., application of EZA caused a reduction of 42.8% s. 
This is quite close to the effect determined with β. But the EZA effect observed with ρadap and β 
is much stronger then the effect observed with lactate imaging. The effect observed with ρfixed 
is much closer to the effect observed with lactate imaging. Thus, additional evidence for the 
advantage of ρadap and β over ρfixed is needed. This evidence is derived from the determination 
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of the Km for lactate induced JA/B in mouse cardiomyocytes. For the ρfixed calculated JA/B a Km of 
15 mM was determined, whereas β calculated JA/B provides a Km 10 mM. The ρadap calculated 
JA/B reveals a Km of 7.6 mM. This is much closer to the Km of 2 mM as determined by lactate 
imaging. Since the MCT1 is the only MCT that was detected in the mouse heart and since its 
Km was determined to be 3.5 mM in Xenopus oocytes (Bröer et al., 1998), the true Km should 
be found in the range below 10 mM. Thus, based on the Km determination, ρadap is the most 
reliable measure for the cellular H+ buffering ability.  
 
4.3 Lactate transport and physiological implementation 
 
The heart is a highly oxidative tissue (Ventura-Clapier et al., 2003). Glucose, fatty acids and 
lactate are reported to be utilised to meet cardiomyocytes’ energy needs (Baker et al., 1998; 
Bergman et al., 2009; Gertz et al., 1988; Gladden, 2007; Johannson et al., 2001; Kemppainen 
et al., 2002; Wahl et al., 2009). Consequently, it produces CO2.  As CO2 equilibrates in water 
with HCO3- and H+, its release potentially acidifies the cell. Therefore it appears plausible to 
minimize the residence time in the cytosol. CO2 diffuses as fast as 1.85-1.89 x 105 cm2/s at 
25°C in water (Unver and Himmelblau, 1964 Maharajh and Walkley, 1972), so it may quickly 
reach the membrane and leave the cell if it is not hindered. Intracellular CA activity would slow 
down the CO2 efflux, because HCO3- is reported to have a diffusion coefficient in water of 1.185 
x 10-5 cm2/s (Vanysek, 2000) and was calculated to be even slower in the cytosol (77 x 10-7 
cm2/s, Swietach et al., 2003). H+ diffuse, as previously mentioned, slow inside cardiomyocytes 
(8-12 x 10-7 cm2/s Zamboni et al., 2003). Thus, the intracellular conversion of CO2 does not only 
cause intracellular H+ load, but also slows down the efflux of CO2. Hence, the absence of 
cytosolic CA activity might be beneficial for the release of CO2 from mouse cardiomyocytes. In 
contrast, extracellular CA might convert cell derived CO2 to HCO3- and H+ and thereby keeps 
the CO2 gradient steep. In addition, HCO3- and H+ could not arbitrarily diffuse across the tissue 
but their movement would rely on buffering and HCO3- transporting mechanisms, so it can be 
regulated. Heming et al. (1994) reported that just extracellular CA activity is contributing to CO2 
equilibration across alveolar capillaries which might be similar in cardiomyocytes. Vandenberg 
et al. (1996) refer the original idea of a beneficial effect of missing cytosolic CA activity on the 
CO2 venting to Roughton (1935), thus it is not a very recent hypothesis. Vandenberg et al. 
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(1996) could show that extracellular but not intracellular CA activity supports CO2 venting in the 
ferret heart. In this work, extracellular but not intracellular CA activity was observed, which 
allows the speculation that in the mouse heart CO2 venting depends on extracellular CA activity, 
too. The extracellular conversion of CO2 to HCO3- and H+ might support the uptake of lactate 
via MCT as it provides H+. At the same time, the extracellular formation of HCO3- might support 
the cellular HCO3- uptake via NBC. If the NBC was more active, HCO3- influx would increase 
and thereby support intracellular H+ buffering. Consequently, the intracellular H+ load, caused 
by MCT, would reduce and allow faster lactate influx. The functional interaction of MCT and 
NBC has been shown by Becker et al. (2004) in Xenopus oocytes and the functional interaction 
of NBC and extracellular CA has been observed as well (Alvarez et al., 2003; Morgan et al., 
2007; Orlowski et al., 2012). Wetzel et al. (2001) showed that the lactate uptake into skeletal 
muscle depends on the activity of extracellular CA. This might indicate a functional interaction 
of MCT and extracellular CA but, according to the mentioned interactions CA/NBC and 
NCB/MCT, it is also thinkable that the observed effect is due to an indirect interaction of 
extracellular CA and MCT via NBC (CANBCMCT). 
 
Figure 50 Model of potential catalytic interaction of MCT and intracellular CA 
The catalytic activity of cytosolic carbonic anhydrase (CA) might slow down the cytosolic acidification, 
caused by lactate uptake via MCT. In this case, the inhibition of CA with EZA would lead to faster 
cytosolic acidification when lactate is applied to the cells. 
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In this work, no intracellular CA activity was observed but inhibition of CA activity with EZA did 
speed up the lactate-induced cytosolic H+ load. In Figure 50, the mechanism of a potential 
speed up of lactate-induced cytosolic H+ load as caused by inhibition of a theoretical 
intracellular CA is shown. In contrast, an extracellular CA activity might provide H+ for the MCT 
but could not slow down the hereby caused cytosolic H+ load at the same time, unless an 
additional interaction comes into play (Figure 51). If the extracellular CA would support the 
NBC, it could slow down the cytosolic H+ load, caused by MCT (Figure 53). 
 
 
Figure 51 Model of potential catalytic interaction of MCT and extracellular CA 
The catalytic activity of extracellular carbonic anhydrase (CA) might speed up the lactate uptake via MCT. In this 
case, the inhibition of CA with EZA would lead to slower cytosolic acidification when lactate is applied to the cells. 
 
In this work, the acid extruding-, cariporide insensitive-, CO2/HCO3-- and Na+-dependent JA/B is 
expected to be mediated by NBC. This activity is reduced from 2.6 mM/min to 0.56 mM/min 
when CA is inhibited, which is a reduction of 78.4%. Consequently it can be concluded that 
NBC activity in mouse cardiomyocytes is highly dependent on extracellular CA activity. The 
lactate-induced JA/B and the lactate influx, as determined by SNARF and Laconic imaging, were 
reduced by 42% and 27%, respectively, when CA was inhibited with EZA. To test if lactate 
uptake depends on NBC activity, the inhibitor S0859 was used. Ch’en et al. (2008) reported 
that S0859 completely inhibits CO2/HCO3--dependent acid extrusion in rat cardiomyocytes 
when applied at a concentration of 30 µM. In this work it is shown that S0859 only partially 
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inhibited CO2/HCO3--dependent acid extrusion from mouse cardiomyocytes. In addition, it was 
found that it reduces lactate induced acidification, which cannot be due to inhibition of NBC 
(Figure 52). Since another commonly used NBC inhibitor, DIDS (4,4’-diisothiocyanostilbene-
2,2’-disulfonic acid Chen et al., 2012; Grichtchenko et al., 2001), is known to inhibit the MCT1 
(Wilson et al., 2009), it is possible to assume the same for S0859. Ch’en et al. (2008) described 
this inhibitor as specific for NBC and they could rule out a side effect on the acid/base 
transporters NHE, AE1, AE2 and CHE. An effect on MCTs was not tested in that publication, 
even though the authors explicitly mention this possibility. Experiments by Sina Ibne Noor with 
Xenopus oocytes expressing MCT4 (unpublished data) revealed an inhibiting effect of S0859 
on MCT. Therefore, the effect of NBC on MCT has not been ultimately proven in this work. 
 
In the introduction, it was mentioned that MCT and NHE might be co-localised in intercalated 
disks (Garciarena et al., 2013; Halestrap et al., 1997). Since interaction between NHE and CAII 
has been reported (Li et al., 2002; Orlowsky and Grinstein, 2004), it was thinkable that the 
observed effect of EZA on the lactate influx might be due to a functional interaction of NHE and 
extracellular CA. The main argument against an interaction of MCT and NHE was the [H+]i 
Figure 52 Scheme of S0859 effect on lactate-induced acidification 
The NBC inhibitor S0859 is reported to completely block NBC activity in rat cardiomyocytes by Ch’en et al. 
(2008) at a concentration of 30 µM. As NBCs are meant to counteract cytosolic H+ load, its activity is 
supposed to slow down lactate induced acidification. Consequently, its inhibition must result in faster lactate 
induced acidification. 
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threshold of NHE that had been reported to be approximately pH 6.9 in guinea-pig 
cardiomyocytes (Leem et al., 1999). In this work, during application of extracellular lactate at a 
concentration of 3 mM, the cytosolic pH dropped in average to a minimum of pH 7.06 in HEPES-
only and CO2/HCO3--buffered conditions. The acid extrusion in HEPES-only-buffered 
conditions was calculated to stop at pH 6.82, whereas in CO2/HCO3--buffered conditions acid 
extrusion was calculated to persist until pH 7.0. This threshold in HEPES-only-buffered 
conditions is most likely due to NHE inactivation. Therefore, the threshold for NHE in mouse 
cardiomyocytes is considered to be pH 6.82. Thus, application of lactate at a concentration of 
3 mM could not have activated the NHE. This was confirmed with lactate imaging, where 
inhibition of NHE with cariporide (30 µM) did not have any effect on the lactate influx. Hence, 
the NHE can be excluded from the observed effect by EZA. 
However, a coupling of cellular CO2 release and lactate uptake is likely. Since oxidative lactate 
consumption leads to cellular CO2 release, the interplay of extracellular CA, NBC and MCT 
might be a feedback mechanism by which increased cellular respiration stimulates the uptake 
of monocarboxylates (Figure 53).  
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This idea was further investigated by the extracellular application of lactate in HEPES-only-
buffered solution, either gassed with 100% O2 or 100% N2 (Figure 54). When the solution was 
gassed with 100% N2 it was assumed that the TCA cycle would stop due to NADH accumulation 
and consequently CO2 release would stop as well. In contrast, the solution gassed with 100% 
O2 was assumed to allow respiration and CO2 formation. In addition, the gassing with 100% O2 
or 100% N2 shall drive out all other gasses, so that those solutions might be considered as CO2 
free.  
Figure 53 Model of NBC, CA and MCT interaction  
As no cytosolic carbonic anhydrase activity was observed, the effects of EZA on lactate induced 
acidification and lactate influx must be caused by inhibition of extracellular CA. But inhibition of 
extracellular CA cannot speed up the cytosolic, lactate induced acidification, unless it interacts with 
another acid/base regulator like NBC. 
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The lactate-induced acidification was 12.6% faster in N2 than in O2 gassed solution. When the 
CA was inhibited with EZA in O2 gassed solution, lactate-induced acidification did speed up by 
8%. This is interpreted as the effect of cell-derived CO2 on the lactate-induced acidification. The 
CO2 is thought to leave the cell and to be converted at the extracellular cell surface to HCO3- 
and H+. The HCO3- may than be reimported into the cell and support the CO2/HCO3--dependent 
H+ buffering. 
Several authors described the heart’s ability to consume lactate. Baker et al. (1998) could show 
that red muscle (soleus) and the heart take up lactate. This uptake increases with training and 
is mediated by MCT1 (in rat). Gertz et al. (1988) found that the human heart takes up lactate 
Figure 54 Potential interaction of respiration and lactate uptake 
If the cells are kept in HEPES-only-buffered solution, gassed with 100% N2 all residual O2 should be driven 
out of the cells and mitochondrial CO2 formation should stop. 
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with a rate of 35 µmol/min at rest. This rate increases during exercise to 120.4 µm/min. Lactate 
labelled with 14C revealed that the lactate that had been taken up was completely converted to 
CO2. In contrast, just 26% of the glucose that had been taken up by the heart was converted to 
CO2 at rest. During exercise, the oxidative glucose turnover increased to 52.6%. 12.3% of the 
glucose, taken up from the blood was converted to lactate (5.7 µmol/min) and 60% entered 
glycogen stores. The heart was found to take up lactate with a rate of 120.4 µmol/min from the 
blood and to release lactate with a rate of 16.2 µmol/min during exercise. These findings are in 
line with the more recent results by Bergman et al. (2009), who also report myocardial lactate 
uptake and release at the same time. According to them, the myocardial lactate release 
increases from approximately 25 µmol/min at rest to 75 µmol during exercise. The myocardial 
lactate consumption increased from approximately 80 µmol/min at rest to 200 µmol/min during 
exercise. Kemppainen et al. (2002) reported that the myocardial glucose uptake increased from 
rest to 30% VO2,max, was stable at 55% and reduced at 75%. 
In this work, the consumption of lactate via conversion to pyruvate by cardiomyocytes was 
confirmed on the single cell level with lactate imaging. When lactate was applied to the cells in 
presence of glucose (1 mM), the cytosolic lactate concentration rose. Then the MCT inhibitor 
AR C155858 was applied to the cells at a concentration of 300 nM (Ovens et al., 2010). This 
caused a drop in cytosolic lactate and was interpreted as lactate consumption. The measured 
lactate consumption was 10 times slower than the lactate influx when lactate was applied at a 
concentration of 0.5 mM to the cells. This means that the reported blood lactate concentration 
of approximately 1 mM at resting conditions (Bergman et al., 2009; Kemppainen et al., 2002) 
would be sufficient to meet the cardiomyocytes lactate demand.  
Inhibition of the respiratory chain with NaN3 (5 mM) in the presence of the MCT inhibitor AR 
C155858, resulted in an immediate increase of the intracellular lactate concentration. To relate 
the lactate consumption to the overall energy metabolism of mouse cardiomyocytes, the 
following assumptions were made: 
(1) Since, under those conditions, no lactate can leave the cell or get consumed, the speed 
of lactate formation reflects the speed of glycolysis.  
(2) This speed of glycolysis reflects the cellular ATP demand.  
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(3) Each lactate consumed for oxidative phosphorylation converts its potential energy to 14-
15 molecules ATP.  
Hence, the rate of lactate consumption must be multiplied with 14-15 to compare its contribution 
to the cellular ATP supply with the contribution by glycolysis. Like this, the ATP provided by 
lactate consumption is calculated to be 106%-114% of the ATP provided by glycolysis, if the 
oxidative phosphorylation is inhibited. This would mean that the blood lactate concentration in 
resting conditions would be sufficient to meet the cardiomyocytes ATP demand. The logical 
consequence of this would be that cardiomyocytes stop ATP production from glucose if an 
adequate amount of lactate is provided. However, the energy demand of cardiomyocytes in the 
used system may not reflect the in vivo situation because the cells were quiescent by the 
absence of extracellular calcium, the application of contraction inhibitor and the lack of 
pacemaker stimulation. 
When the MCT was inhibited in the absence of extracellular lactate, the cytosolic lactate 
concentration rose. Compared with the lactate formation in the presence of NaN3 (5 mM) and 
the MCT inhibitor AR C155858, the steady state lactate formation contributes to the total ATP 
production with 5.7%. Gertz et al. (1988) measured a myocardial lactate uptake of 34.9 
µmol/min at resting conditions. This lactate was completely converted to CO2. The myocardial 
glucose uptake was determined to be 28.33 µmol/min. 12.3% of this glucose was converted via 
glycolysis to lactate and 26% percent were converted to CO2. It is assumed that out of 1 
molecule glucose 30-32 molecules ATP are generated (Schmidt et al, 2005; Pfeiffer et al., 
2001) if converted to CO2. The conversion of glucose to lactate generates 2 molecules of ATP. 
Thus, according to the data reported by Gertz et al., (1988), the oxidative consumption of lactate 
and glucose generates ATP with a rate of 506 µmol/min and 228 µmol/min, respectively. The 
conversion of glucose to lactate generates additional ATP with a rate of 7 µmol/min. Thus, the 
total rate of human myocardial ATP formation under the assumed conditions is 741 µmol/min. 
The fraction of glycolysis that exceeds the speed of oxidative phosphorylation contributes with 
0.94% to the total ATP formation. This is less than the 5.7% as assumed for isolated mouse 
cardiomyocytes in this work, but it lies within a similar range. The difference might be due to 
the fact that Gertz et al. (1988) just considered the lactate formation from exogenous glucose 
and could not take into account the lactate formation from glycogen stores, whereas in this work 
the total lactate formation is considered. Anyway, since the compared systems are very 
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different, a difference in this value must be expected. Thus, it can be concluded that in the 
steady state of the used system, glycolysis slightly exceeds the oxidative phosphorylation, 
which results in slow cytosolic lactate formation. 
The release of lactate and its net consumption at the same time are contradictory, unless 
cardiomyocytes undergo a metabolic switch in the presence of lactate. This will be discussed 
in the next section. 
 
4.4 Final conclusion, model & further speculations 
 
During this work it was shown that mouse cardiomyocytes 
(1) possess NHE activity  
(2) possess electro-neutral NBC or NBC-like activity  
(3) mediate lactate uptake via MCT1  
(4) lack cytosolic CA activity  
(5) possess extracellular CA activity  
(6) import lactate faster if the extracellular CA is active  
(7) consume and produce lactate 
(8) produce pyruvate out of lactate  
Furthermore this work provides evidence for 
(9) different HCO3--dependent acid extruding mechanism that include a S0859-sensitive, 
a S0859-insensitive and a Na+-independent fraction  
(10) impact of cellular respiration on cytosolic H+ buffering  
(11) unspecific inhibition of the MCT1 by S0859. This was further confirmed in Xenopus 
oocytes expressing the MCT4 by Sina Ibne Noor (unpublished data). 
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The findings of this work are summarized in Figure 55. The CO2 released from the cells during 
oxidative metabolism may support further uptake of MCT1 substrates, such as lactate. In turn, 
further consumption of lactate in the citric acid cycle will go along with CO2 release. Therefore, 
an auto regulation of lactate uptake by cellular respiration is postulated. When lactate was 
applied to the cells in HEPES-only-buffered solution gassed with 100% N2, the  
∆ [H+]i/∆t was 12.6% faster compared to lactate application in medium gassed with 100% O2. 
But for different reasons, this effect might be under estimated due to the used system: 
(1) The cells were isolated and because of continuous perfusion, the artificial extracellular 
space became non-finite. Consequently, CO2 leaving the cell might be converted by 
extracellular CAs but the resulting HCO3- would be partially washed away, thus less can 
be reimported by NBC.  
(2) The cells were quiescent and experiments were performed at room temperature so that 
the overall cell energy turnover most likely had dropped. This can be assumed based on 
the finding that cardiomyocytes show hibernation if they are exposed to severe energy 
stress (Cadenas et al., 2010; Casey and Arthur, 2000), hence, the forced inhibition of 
contractile activity should work the other way around and save energy. Therefore, the 
cells may not have provided the rate of CO2 release that might occur in the intact and 
active heart. Especially when the heart rate increases, the release of CO2 may rise and 
thereby stimulate further uptake of energy substrates.  
(3) The inhibition of oxidative phosphorylation will result in a rapid lactate formation which 
might inhibit further lactate uptake.  
(4) The myoglobin will provide an oxygen buffer whose extend has not been determined 
during this work. 
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Thus, in vivo the effect of cellular CO2 release on the lactate transport might be much more 
significant than in vitro. 
Gertz et al. (1988) and Bergman et al. (2009) reported the controversial behaviour of the human 
heart to consume and release lactate at the same time, which results in a net uptake. According 
to Bergman et al. (2009), this lactate uptake contributes with 4.9% at rest and 15% during 
exercise to the overall body lactate disposal. In this work, this contrariness was scaled down to 
the single cardiomyocytes. On the one hand they were shown to consume lactate if applied, 
but on the other hand they were shown to produce lactate if absent in the extracellular space. 
Figure 55 Final model of CA, NBC, MCT and mitochondrion interaction 
The lactate is taken up into the cell by the MCT1 and is converted to pyruvate in the cytosol. This fuels 
mitochondria. The rise in cytosolic pyruvate might stimulate mitochondrial CO2 release, which in turn would 
reduce the lactate-induced acidification. This reduction is abolished when the extracellular carbonic 
anhydrase (CA) is inhibited. Consequently, the extracellular CA must provide a catalytic support to an 
acid/base regulator that reduces the cytosolic acidification. Since it is shown that this is not the NHE, the 
remaining candidates are NBCs or NBC-like acid/base regulators. In this work it was not achieved to figure 
out which of those is present in mouse cardiomyocytes. 
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According to the previously mentioned assumptions for the energy metabolism, cardiomyocytes 
completely meet their ATP demand from lactate if applied (in the used conditions). In this work 
it was shown that extracellular lactate application leads to enhanced cytosolic pyruvate 
formation, thus glycolysis might be hindered if cells take up lactate. Based on the previously 
made assumptions, glycolytic ATP generation contributes with 11.25% (5.7% lactate forming 
glycolysis, 5.5% glycolysis driving TCA) to the total ATP generation, if glucose is the only energy 
substrate. It appears unlikely that the consumption of lactate is just a compensation for the lost 
ATP production due to cytosolic lactate load, because the assumed ATP production from 
lactate consumption (122%) exceeds the 11.25% by far. A more complex explanation might be 
similar to theories about the astrocyte-neuron-lactate shuttle (Chih and Roberts, 2003): if lactate 
or fatty acids are used for energy generation, glucose may be saved for the pentose phosphate 
way, which is needed for the glutathione reduction (Takahashi et al., 2012).  
The ROS in cardiomyocytes are produced in big parts in the respiratory chain at complex III 
(Ghosh et al., 2005), so the activity of the oxidative metabolism is directly linked to ROS 
formation. Therefore, stimulation of the respiratory chain, either by hyperglycemia or by 
increased energy needs, may raise the mitochondrial ROS production. ROS formation may 
lead to muscle fatigue via reduced Ca2+ sensitivity (Reid, 2008 review). This means that ROS 
formation during strong respiratory activity would, in addition to being toxic anyway, decrease 
the myocardial endurance as well. Therefore cardiomyocytes must be protected from ROS.  
So glucose is needed to compensate the ROS formation via pentose phosphate way and 
glutathione reduction. But if big amounts of glucose get available to cardiomyocytes, like under 
diabetic conditions, this may have the opposite effect and cause ROS formation as shown by 
Fiordaliso et al. (2004) and Ye et al. (2003). This might be due to excessive demand of the 
respiratory chain as shown by Nishikawa et al. (2007) in cultured aortic endothelial cells. 
Therefore the cellular glucose must be “guided” to the pentose phosphate way. 
Jain et al. (2003) could show that the glucose-6-phosphate dehydrogenase, the rate limiting 
enzyme of the pentose phosphate pathway, is stimulated by ROS in rat cardiomyocytes. In 
addition, Leite et al. (2011) could find direct inhibition of the phosphofructokinase by lactate. 
Herrero-Mendez et al. (2009) could show that artificial stimulation of neuronal glycolysis via 
phosphofructokinase activation inhibits the pentose phosphate way. So inhibition of the 
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phosphofructokinase with lactate, as reported by Leite et al. (2011) might just work the other 
way around and stimulate the pentose phosphate pathway.  
If this is considered all together, strong physical activity might stimulate the pentose phosphate 
way by glucose-6-phosphate dehydrogenase stimulation with ROS on the one hand and with 
lactate uptake, inhibiting the phosphofructokinase, on the other hand (Figure 56 and Figure 57).  
Especially during strong physical activity where the blood lactate level was measured to reach 
up to 10 mM in humans (Kemppainen et al., 2002) it appears plausible, that oxidative tissues 
such as the myocardium increase the lactate consumption to meet their energy needs. Lactate 
may be converted to the glycolytic end product pyruvate, which was confirmed in this work by 
pyruvate imaging. In addition to the direct inhibition of the glycolysis via phosphofructokinase 
inhibition by lactate, the increased cytosolic pyruvate and consequently decreased NAD+ levels 
(since conversion of lactate to pyruvate produces NADH out of NAD+) following lactate uptake 
must inhibit the glycolysis additionally. The herby crotched glucose might be used for NADPH 
production in the pentose phosphate way, which is needed in turn to reduce glutathione 
(Herrero-Mendez et al., 2009; Takahashi et al., 2012, see the model here in Figure 57).  
This hypothesis is further supported by the findings of Kemppainen et al. (2002). They could 
show that human myocardial glucose uptake during exercise is elevated at 30% and 55% 
VO2max. compared to resting conditions but reduces when the training intensity is increased to 
75% VO2max.. This is in contrast to the glucose uptake in skeletal muscle, where it increases with 
increased workload, also at 75% VO2max exercise. In addition they could measure an increase 
in plasma lactate concentration from approximately 1 mM at resting conditions to approximately 
9.5 mM at 75% VO2max exercise, whereas the blood glucose level remained between 5 and 6.5 
mM. Thus, the main myocardial ATP metabolism might have switched from respiratory glucose 
to lactate consumption. The physiological meaning of this might be the myocardial protection 
from ROS (Figure 56 and Figure 57). 
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During this work, it was not possible to measure the cytosolic glucose in mouse 
cardiomyocytes. Therefore, a glucose saving effect by lactate consumption remains 
speculative. Tsai et al. (2005) could show that cytosolic presence of another mitochondrial 
energy substrate, D-3-hydroxybutyrate, in rat cardiomyocytes decreases the glucose 
consumption. Since the blood glucose level remains constant between 5 mM and 6.5 mM 
(Kemppainen et al., 2002), cardiomyocytes should be able to keep the cytosolic glucose 
concentration constant as well. Still, lactate consumption might save glycogen stores for other 
cellular processes than ATP production. A correlation between lactate consumption and ROS 
formation remains to be tested.  
Figure 56 Potential stimulation of pentose phosphate pathway by lactate and ROS 
The glycolysis is shown in black, the pentose phosphate way in red and the potential impact of lactate in 
green. 
The uptake of lactate leads to an increase in cytosolic pyruvate. As pyruvate is the end product of the 
glycolysis, this increase in cytosolic pyruvate must slow down the glycolysis. In addition, Leite et al. (2011) 
could show that lactate inhibits the phosphofructokinase. Since, according to this hypothesis, the glycolysis 
gets inhibited by the uptake of lactate, more glucose-6-phosphate is available for the pentose phosphate way. 
Jain et al. (2003) could show that ROS may stimulate the glucose-6-phosphate dehydrogenase, which is the 
rate limiting enzyme of the pentose phosphate way. Both, the increase in ROS formation and the increased 
lactate uptake can be expected to occur during strong physical activity. Therefore, the consumption of lactate 
by cardiomyocytes might serve as protection from ROS.  
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As this idea is still at the level of a hypothesis, it contains some minor gaps in line of 
argumentation. The major one of those is caused by the findings of Kemppainen et al. (2002) 
and Tsai et al. (2005), who show that either heavy work load or application of alternative energy 
substrates (D-3-hydroxybutyrate) lead to reduced glucose uptake into the heart. If the use of 
this hypothetical metabolic switch would be that glucose gets saved for the pentose phosphate 
way, the cellular glucose uptake should remain the same, since it would still be needed, just in 
a different pathway.  
 
Figure 57 Final model with hypothetical ROS protection by lactate  
According to this model, increased respiratory activity is followed by increased CO2 release. This 
stimulates lactate uptake. The lactate is converted to pyruvate, which is being consumed in the 
mitochondria. As the elevated cytosolic lactate levels lead to an elevated pyruvate level, the glycolysis 
most likely slows down. In addition, lactate might directly inhibit the phosphofructokinase and herby 
slow down glycolysis (Leite et al., 2011). At the same time, increased ROS levels may stimulate the 
pentose phosphate way (Jain et al., 2003). 
EZA: CA inhibitor, ROS: reactive oxygen species, pyr-: pyruvate 
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But if this postulated regulation would be a bit more elaborated than just inhibition of a 
biochemical process by elevated product concentrations, the total cellular glucose utilization 
could drop down if the cell faces cytosolic lactate load. Such regulation would include the above 
mentioned mechanisms of phosphofructokinase inhibition and glucose-6-phosphate 
dehydrogenase activation and maybe some further more. If the extreme case of an oxidative 
pentose phosphate pathway is assumed, where the end-products fructose-6-P and 
glyceraldehyde-3-P are continuously reused for glucose-6-P generation, much less glucose 
would be needed to meet the cellular NADPH needs. This might explain the observed drop in 
myocardial glucose consumption at heavy work load as observed by Kemppainen et al. (2002).  
If the model shown in Figure 57 is scaled down to transient, regional effects within the heart 
tissue, it would not be controversial to the findings by Gertz et al. (1988) and Bergman et al. 
(2009), who reported that the human heart possesses continuous lactate release and uptake. 
According to Pfeiffer et al. (2001), the ATP production via fermentation is beneficial if ATP is 
needed fast. Thus, at rest or during moderate exercise, lactate formation might occur in 
cardiomyocytes during contraction. Oxidative phosphorylation might consume all pyruvate 
provided by glycolysis and lactate conversion in the intermediate phases of relaxation. During 
strong exercise (75 % VO2max) the elevated blood lactate level might counteract myocardial 
lactate formation and according to the metabolic model in Figure 56 and Figure 57, the 
utilisation of glucose might be favoured by the pentose phosphate pathway due to ROS 
formation. 
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4.5 Potential MCT / NHE interaction 
 
As mentioned in the introduction, the reported co-localisation of MCT and NHE at the 
intercalated discs of cardiomyocytes opens the possibility of an interaction. Even though in this 
work no effect of NHE on the lactate uptake was observed, the used conditions differ from the 
in vivo situation. The NHE is reported to be regulated by many stimuli so that its threshold and 
overall activity might differ according to metabolic state and myocardial activity. For example 
Ca2+ is reported to stimulate the NHE activity (Bertrand et al., 1994; Vaughan-Jones et al., 
2008; Wakabayashi et al., 1997), so that the transporter might get activated in the same rhythm 
as the cell contracts, since each contraction follows a cytosolic rise in Ca2+. So, the NHE might 
stimulate lactate uptake each time the cell contracts. In addition, ROS are reported to stimulate 
NHE activity (Vaughan-Jones et al., 2008), which would fit very well to the hypothesis that 
lactate uptake and consumption might serve as ROS protection. In this case, the NHE might 
get active when the ROS production becomes critical and stimulate the MCT activity. As 
consequence, in accordance to the above mentioned hypothesis, the pentose phosphate 
pathway would get stimulated.   
4.6 Non-catalytic interaction of extracellular CA and MCT 
In this work, a non-catalytic interaction of MCT1 and the extracellular CAs CAIV, CAIX or CAXIV 
was not observed in mouse cardiomyocytes. This might be due to different reasons. First of all, 
the presence of CAIV and CAIX on mouse cardiomyocytes, as reported by Scheibe et al. 
(2006), was not confirmed in this work. Second, if a non-catalytic interaction between MCT1 
and any CA in mouse cardiomyocytes would have a significant impact on the cellular 
physiology, it is very likely that its loss in a knockout animal is compensated. For example, the 
MCT1 or other CA isoforms might get upregulated in the knock out animal, so that no difference 
between WT and KO animal could be observed. This was not tested during this work because 
it would just explain why the non-catalytic interaction cannot be observed but it would not prove 
its existence. To avoid compensatory regulations, it might be necessary to disrupt the potential 
non-catalytic interaction during a live cell imaging experiment. This might be done with an 
antibody that prevents the CAIX and/or CAXIV from getting into close proximity to the MCT1. 
Before this could be done in cardiomyocytes, this technic should be tested first in Xenopus 
oocytes that contain MCT1 and CAIX and/or CAXIV. 
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